{"gene":"MST1","run_date":"2026-06-10T02:59:51","timeline":{"discoveries":[{"year":1996,"finding":"MST1 homodimerizes via its extreme C-terminal 57 amino acids, and contains an inhibitory domain within a central 63-amino acid region whose removal increases kinase activity ~9-fold. Loss of dimerization alone does not affect kinase activity, but a molecule lacking both the dimerization and inhibitory domains is less active than one lacking only the inhibitory domain. MST1 also associates with a high molecular weight complex in cells.","method":"C-terminal and internal deletion analysis, co-immunoprecipitation, yeast two-hybrid, in vitro cross-linking, size exclusion chromatography","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (Co-IP, yeast two-hybrid, cross-linking, size exclusion) with deletion mutagenesis in a single focused study","pmids":["8702870"],"is_preprint":false},{"year":1998,"finding":"MST1 is specifically cleaved by caspase-3-like activity (blocked by ZVAD-fmk, DEVD-CHO, and CrmA) during Fas/CD95- or staurosporine-induced apoptosis, removing the C-terminal regulatory domain and activating MST1. Overexpression of wild-type or truncated MST1 induces apoptotic morphology; kinase-dead MST1 does not. Activated MST1 activates MKK6, p38 MAPK, MKK7, and SAPK in co-transfection assays. MST1 can also activate caspases that in turn cleave it, forming a positive feedback loop.","method":"Caspase inhibitor experiments, in vivo cleavage assays, overexpression of wild-type and kinase-dead mutants, co-transfection kinase activation assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (inhibitor pharmacology, mutagenesis, overexpression) replicated across stimuli in one focused study","pmids":["9545236"],"is_preprint":false},{"year":2001,"finding":"Caspase-mediated cleavage of MST1 releases the C-terminal domain containing two functional nuclear export signals (NESs), causing nuclear translocation of the N-terminal kinase domain. Full-length MST1 is cytoplasmic; truncation of the C-terminal domain, NES point mutation, or leptomycin B treatment causes nuclear localization. Nuclear MST1 is more efficient at inducing chromatin condensation; inhibiting cleavage-site mutation reduces chromatin condensation ability.","method":"NES mutation, leptomycin B treatment, subcellular fractionation/localization, staurosporine-induced apoptosis assays, kinase-negative mutant expression","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (mutagenesis of NES, pharmacological export inhibition, cleavage-site mutation) in one focused study","pmids":["11517310"],"is_preprint":false},{"year":2001,"finding":"MST1 promotes apoptosis through JNK activation: dominant-negative JNK inhibits MST1-induced morphological changes and caspase-3 activation. MST1 induces CAD-mediated DNA fragmentation via caspase-dependent pathway and induces chromatin condensation and membrane blebbing through a caspase-independent JNK pathway. p38 MAPK is not required for MST1-induced apoptosis.","method":"Dominant-negative JNK co-expression, p38 inhibitor (SB203580), caspase inhibitors, ICAD expression, morphological assays","journal":"Genes to cells : devoted to molecular & cellular mechanisms","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis by dominant-negative and pharmacological inhibitors, two orthogonal readouts, single lab","pmids":["11442632"],"is_preprint":false},{"year":2002,"finding":"MST1 activation requires phosphorylation at Thr183 (primary site) and Thr187 in subdomain VIII, catalyzed by intermolecular autophosphorylation enhanced by homodimerization. Active MST1 also autophosphorylates at Thr177 and Thr387. Active MST1 activates JNK, caspase-3, and caspase-9. Kinase activity (not caspase cleavage) is required for apoptotic cell detachment. An S327E phosphomimetic mutant confers caspase resistance.","method":"Site-directed mutagenesis of phosphorylation sites, in vitro kinase assays, cell detachment and apoptosis assays with phospho-mimetic and phospho-dead mutants","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assays with systematic mutagenesis, multiple phosphorylation sites mapped, multiple orthogonal cellular readouts","pmids":["12223493"],"is_preprint":false},{"year":2002,"finding":"Death-associated protein 4 (DAP4) binds MST1 through its carboxyl-terminal segment and co-localizes with MST1 in cells. DAP4 does not alter MST1 kinase activity but augments MST1-induced apoptosis in a dose-dependent manner when co-expressed with sub-maximal MST1. MST1-induced apoptosis is suppressed by dominant-negative p53, and DAP4 binds p53, potentially enabling MST1 colocalization with p53.","method":"Co-immunoprecipitation, overexpression co-transfection apoptosis assays, dominant-negative p53, in vitro kinase assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — reciprocal Co-IP and in vitro binding, functional augmentation assay, single lab","pmids":["12384512"],"is_preprint":false},{"year":2006,"finding":"RASSF1/Nore1 polypeptides bind MST1 and MST2 through SARAH domain interactions. Recombinant MST1/2, spontaneous dimers, autoactivate in vitro through intradimer transphosphorylation of the activation loop; Nore1/RASSF1 polypeptides inhibit this autoactivation. Membrane-recruited MST1 is strongly activated in vivo; MST1 bound to RasG12V through Nore1A is activated.","method":"In vitro kinase reconstitution, SARAH domain binding assays, membrane recruitment experiments, co-immunoprecipitation of endogenous complexes","journal":"Methods in enzymology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution of autoactivation and inhibition by RASSF/Nore1, single lab review/methods paper","pmids":["16757333"],"is_preprint":false},{"year":2007,"finding":"MST1 is a physiological interaction partner of Akt1, identified in lipid raft-enriched fractions from prostate cancer cells. Endogenous MST1 (and MST2) inhibit endogenous Akt1 activity. Both full-length MST1 and its two caspase cleavage products complex with and inhibit Akt1. MST1 cRNAs revert an early lethal phenotype in zebrafish induced by membrane-targeted Akt1.","method":"Co-immunoprecipitation from lipid raft fractions, endogenous kinase activity assays, zebrafish rescue experiments","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — endogenous Co-IP, functional rescue in zebrafish, single lab with two orthogonal systems","pmids":["17932490"],"is_preprint":false},{"year":2008,"finding":"MST1 and MST2 are activated during mitosis (especially in nocodazole-arrested cells). MST1/2 phosphorylate MOBKL1A and MOBKL1B (Drosophila MATS homologs) in vitro and in cells in an MST1/2-dependent manner during mitosis and in response to okadaic acid or H2O2. MST1/2-catalyzed MOB phosphorylation promotes MOB binding to LATS1 and enables H2O2-stimulated LATS1 activation loop phosphorylation. Non-phosphorylatable MOB mutant replacement accelerates cell proliferation by speeding G1/S and mitotic exit.","method":"In vitro kinase assays, cell-based phosphorylation with MST1/2 knockdown/overexpression, replacement of endogenous MOB with non-phosphorylatable mutant, cell cycle analysis","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro substrate phosphorylation, cell-based MST-dependent phosphorylation, non-phosphorylatable mutant rescue; multiple orthogonal methods in focused study","pmids":["18328708"],"is_preprint":false},{"year":2008,"finding":"The Nore1B/RAPL-MST1 complex restrains antigen receptor-induced proliferation of naive T cells. MST1-null naive T cells show markedly greater TCR-stimulated proliferation; among known MST1 substrates, only MOBKL1A/B phosphorylation is entirely lost in TCR-stimulated, MST1-deficient T cells. MST1-null T cells exhibit defective LFA-1 clustering. Mst1-null mice have reduced Nore1B/RAPL in lymphoid cells.","method":"MST1 knockout mice, in vitro proliferation assays, substrate phosphorylation analysis, LFA-1 clustering microscopy","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined cellular and molecular phenotype, substrate phosphorylation loss confirmed, replicated across multiple readouts","pmids":["19073936"],"is_preprint":false},{"year":2009,"finding":"MST1 phosphorylates FOXO1 at Ser212 (corresponding to Ser207 in FOXO3), disrupting FOXO1 association with 14-3-3 proteins and promoting FOXO1 nuclear translocation in cerebellar granule neurons deprived of neuronal activity. MST1 is required for neuronal death upon growth factor/activity withdrawal, and MST1 promotes cell death in a FOXO1-dependent manner. The scaffold protein Nore1 is also required for survival factor deprivation-induced neuronal death.","method":"Phosphorylation assays, 14-3-3 co-immunoprecipitation, nuclear translocation imaging, MST1 loss-of-function in primary neurons, FOXO1-dependent rescue experiments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — kinase assay identifying phosphorylation site, 14-3-3 dissociation, nuclear translocation, and FOXO1-dependent cell death, multiple orthogonal methods","pmids":["19221179"],"is_preprint":false},{"year":2009,"finding":"Mst1 and Mst2 are cleaved and constitutively activated in mouse liver. Combined Mst1/2 deficiency leads to loss of inhibitory Ser127 phosphorylation of YAP1, liver overgrowth, and hepatocellular carcinoma. Re-expression of Mst1 in HCC cell lines promotes YAP1 Ser127 phosphorylation/inactivation and abolishes tumorigenicity. Mst1/2 inactivates YAP1 in liver through an intermediary kinase distinct from Lats1/2.","method":"Conditional liver-specific Mst1/2 knockout mice, YAP1 phosphorylation western blot, HCC cell line re-expression with tumorigenicity assays, epistasis analysis","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean conditional KO with defined pathway epistasis and rescue by re-expression, replicated across mouse model and cell lines","pmids":["19878874"],"is_preprint":false},{"year":2009,"finding":"Mst1 is required for lymphocyte trafficking in vivo. Mst1-/- lymphocytes show impaired firm adhesion to high endothelial venules and reduced stopping time on endothelium under physiological shear, defective stabilization of α4 integrin-mediated adhesion, and impaired motility within lymph nodes. L-selectin-dependent rolling/tethering was not affected.","method":"Mst1 knockout mice, in vitro adhesion cascade assays under shear flow, intravital imaging within lymph nodes","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean KO with defined adhesion/migration phenotype, multiple in vitro and in vivo assays, single lab","pmids":["19339990"],"is_preprint":false},{"year":2010,"finding":"Mst1 and Mst2 act redundantly to control organ size and suppress tumorigenesis; combined deletion (Mst1-/-; Mst2-/-) causes early embryonic lethality and is required to control YAP phosphorylation and activity in vivo. TNFα-induced apoptosis is blocked in Mst1/Mst2 double-mutant cells both in vivo and in vitro.","method":"Mst1/Mst2 double-knockout mice, YAP phosphorylation assays, TNFα-induced apoptosis assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic double KO with multiple defined phenotypes, YAP phosphorylation molecular readout confirmed in vivo","pmids":["20080598"],"is_preprint":false},{"year":2010,"finding":"MST1 promotes accurate kinetochore-microtubule attachment by phosphorylating Aurora B directly (in vitro), inhibiting its kinase activity. MST1 depletion increases Aurora B activity and causes unaligned mitotic chromosomes with Mad2/BubR1-dependent spindle checkpoint activation. MST1 and NDR1 (downstream kinase of MST1) associate with Aurora B; NDR1 depletion phenocopies MST1 depletion; Aurora B depletion rescues kinetochore-microtubule attachment defects in MST1/NDR1-depleted cells.","method":"MST1/NDR1 RNAi, in vitro kinase assay (MST1 phosphorylation of Aurora B), co-immunoprecipitation, live-cell microscopy, spindle checkpoint assay","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay showing direct phosphorylation, Co-IP, epistasis by Aurora B depletion rescue, single lab","pmids":["20171103"],"is_preprint":false},{"year":2010,"finding":"PHLPP phosphatases bind MST1 both in vivo and in vitro, dephosphorylate MST1 at inhibitory Thr387, activating MST1 and its downstream effectors p38 and JNK to induce apoptosis. Akt phosphorylates Thr387 to inhibit MST1. PHLPP, Akt, and MST1 form an autoinhibitory triangle controlling apoptosis/proliferation balance.","method":"Co-immunoprecipitation, in vitro phosphatase and kinase assays, mutant MST1 T387 analysis, p38/JNK activation assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro phosphatase assay, Co-IP, kinase assays with mutagenesis, multiple orthogonal methods in single study","pmids":["20513427"],"is_preprint":false},{"year":2011,"finding":"c-Abl tyrosine kinase phosphorylates MST1 at Tyr433, triggering MST1 stabilization and activation. Inhibition of c-Abl promotes MST1 degradation via CHIP-mediated ubiquitination. Oxidative stress induces c-Abl-dependent tyrosine phosphorylation of MST1 and increases the MST1-FOXO3 interaction, activating the MST1-FOXO signaling pathway leading to neuronal cell death.","method":"In vitro kinase assay (c-Abl phosphorylation of MST1), c-Abl inhibitor/RNAi, CHIP ubiquitination assays, co-immunoprecipitation (MST1-FOXO3), primary neuron and hippocampal neuron assays","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro kinase assay with site identification, ubiquitination assay, Co-IP, multiple orthogonal methods in single lab","pmids":["21715626"],"is_preprint":false},{"year":2011,"finding":"MST1 promotes apoptosis in a p53-dependent manner by phosphorylating Sirt1, inhibiting its deacetylase activity and its interaction with p53, thereby increasing p53 acetylation and transactivation. This defines an MST1-Sirt1-p53 signaling axis in DNA damage-induced apoptosis.","method":"In vitro kinase assay (MST1 phosphorylation of Sirt1), co-immunoprecipitation (Sirt1-p53), Sirt1 activity assay, p53 acetylation/transactivation assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — in vitro kinase assay, Sirt1 activity assay, Co-IP; single lab with multiple orthogonal methods","pmids":["21212262"],"is_preprint":false},{"year":2012,"finding":"Mst1 and Mst2 control thymic egress and T cell migration by activating Rho GTPases Rac1 and RhoA. MST1/2-deficient SP thymocytes show abolished sphingosine-1-phosphate- and CCL21-induced Mob1 phosphorylation, Rac1/RhoA GTP charging, and cell migration. When phosphorylated by Mst1/Mst2, Mob1 binds and activates the Rac1 guanyl nucleotide exchanger Dock8.","method":"Mst1/2 double-knockout hematopoietic cells, Mob1 phosphorylation assays, Rac1/RhoA GTP charging assays, Dock8 co-immunoprecipitation with phospho-Mob1, migration assays","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — clean double KO with defined molecular (GTP charging, Mob1 phosphorylation, Dock8 binding) and cellular (migration) phenotypes, multiple methods","pmids":["22412158"],"is_preprint":false},{"year":2014,"finding":"MST1 is activated under diabetogenic conditions in beta cells and directly phosphorylates the beta cell transcription factor PDX1 at Thr11, causing PDX1 ubiquitination and proteasomal degradation, leading to impaired insulin secretion. MST1 also induces mitochondria-dependent apoptosis through upregulation of BIM (BH3-only protein). MST1 deficiency restores normoglycemia and beta cell function in vivo.","method":"In vitro kinase assay (MST1 phosphorylation of PDX1 at T11), ubiquitination assay, MST1 knockout/transgenic mouse models, islet apoptosis assays","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay identifying phosphorylation site, ubiquitination assay, KO/transgenic mouse models with functional rescue; multiple orthogonal methods","pmids":["24633305"],"is_preprint":false},{"year":2014,"finding":"Mst1 promotes cardiac myocyte apoptosis through a K-Ras/RASSF1A/Mst1 complex localized to mitochondria in response to oxidative stress. Activated Mst1 phosphorylates Bcl-xL at Ser14 (within the BH4 domain), antagonizing Bcl-xL-Bax binding and causing Bax activation and mitochondria-mediated apoptosis.","method":"In vitro kinase assay (Mst1 phosphorylation of Bcl-xL at Ser14), co-immunoprecipitation of K-Ras/RASSF1A/Mst1 complex, mitochondrial fractionation, Bax activation assay, cardiac myocyte apoptosis assay","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with site identification, mitochondrial localization of complex, Bax activation, multiple orthogonal methods in single study","pmids":["24813943"],"is_preprint":false},{"year":2014,"finding":"The MST1/2-SAV1 complex promotes ciliogenesis. MST1 localizes to the basal body of cilia and is activated during ciliogenesis. MST1/2 binds and phosphorylates Aurora kinase A (AURKA), leading to dissociation of the AURKA/HDAC6 cilia-disassembly complex. MST1/2-SAV1 also associates with the NPHP transition-zone complex, promoting ciliary localization of ciliary cargoes.","method":"MST1/2 or SAV1 depletion in cultured cells and zebrafish, immunolocalization to basal body, in vitro kinase assay (MST1 phosphorylation of AURKA), co-immunoprecipitation with AURKA/HDAC6 and NPHP complex","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vitro kinase assay, multiple Co-IP, localization, depletion phenotype in cells and zebrafish; multiple orthogonal methods","pmids":["25367221"],"is_preprint":false},{"year":2015,"finding":"Mst1 and Mst2 positively regulate phagocytic ROS production by controlling mitochondrial trafficking to phagosomes. Mst1/2 activate the GTPase Rac to promote TLR-triggered assembly of the TRAF6-ECSIT complex required for mitochondrial recruitment to phagosomes. Inactive Rac2(D57N) disrupts the TRAF6-ECSIT complex by sequestering TRAF6.","method":"Mst1/2 knockout macrophages, Rac activation assays, TRAF6-ECSIT co-immunoprecipitation, mitochondrion-phagosome colocalization imaging, ROS measurement, bactericidal assays","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined molecular (Rac activation, TRAF6-ECSIT complex) and functional (ROS, bactericidal) phenotypes, multiple orthogonal methods","pmids":["26414765"],"is_preprint":false},{"year":2015,"finding":"mTORC2 (Rictor complex) directly phosphorylates MST1 at Ser438 in the SARAH domain, thereby reducing MST1 homodimerization and kinase activity. Cardiac-specific mTORC2 disruption (Rictor deletion) causes marked activation of MST1, leading to cardiac dysfunction and dilation under pressure overload.","method":"In vitro kinase assay (mTORC2 phosphorylation of MST1 at S438), site-directed mutagenesis, cardiac-specific Rictor KO mice, MST1 dimerization and activity assays","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay identifying phosphorylation site, mutagenesis, clean cardiac KO with defined phenotype, multiple orthogonal methods","pmids":["25843706"],"is_preprint":false},{"year":2016,"finding":"Mst1 shuts off cytosolic antiviral defense by directly associating with IRF3 and phosphorylating it at Thr75 and Thr253, abolishing activated IRF3 homodimerization, chromatin occupancy, and IRF3-mediated transcription. Mst1 also impedes virus-induced TBK1 activation, further attenuating IRF3 activation. Mst1 depletion or ablation enhances antiviral response. Mst2 does not have this effect.","method":"Functional kinome screen, in vitro kinase assay (MST1 phosphorylation of IRF3 at T75/T253), co-immunoprecipitation (MST1-IRF3), IRF3 homodimerization assay, chromatin occupancy assay, MST1 KO mice with viral challenge","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vitro kinase assay with site mapping, multiple cell-based assays, KO mice with defined antiviral phenotype, multiple orthogonal methods","pmids":["27125670"],"is_preprint":false},{"year":2016,"finding":"DLG5 functions as an evolutionarily conserved scaffold that links MST1/2 with Par-1 polarity proteins (MARK1/2/3), inhibiting MST1/2 kinase activity and the MST1/2-LATS1/2 association. Hippo signaling is hyperactive in Dlg5-/- tissues; conditional deletion of Mst1/2 fully rescues the phenotypes of brain-specific Dlg5-KO mice.","method":"Affinity purification/mass spectrometry, MST1/2 kinase activity assay in DLG5-null cells, genetic rescue (Mst1/2 conditional deletion in Dlg5-KO), co-immunoprecipitation","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — AP-MS identification, kinase activity assay, genetic epistasis rescue, multiple orthogonal methods","pmids":["28087714"],"is_preprint":false},{"year":2016,"finding":"H-ras promotes formation of inactive Mst1/Mst2 heterodimers via an Erk-dependent mechanism. Mst1/Mst2 heterodimerize in cells through SARAH domains, and these heterodimers have much-reduced kinase activity compared to Mst1 or Mst2 homodimers. Cells lacking Mst1 are resistant to H-ras-mediated transformation and maintain active Hippo pathway signaling.","method":"Co-immunoprecipitation of Mst1/Mst2 heterodimers, SARAH domain deletion/mutation, kinase activity assay of hetero- vs. homodimers, H-ras transformation assays, Mst1-KO cells","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — Co-IP, in vitro kinase comparison, SARAH domain mutagenesis, transformation assay, single lab with multiple orthogonal methods","pmids":["27238285"],"is_preprint":false},{"year":2016,"finding":"Pharmacological inhibition of MST1/2 with XMU-MP-1 (a selective, reversible inhibitor) blocks MST1/2 kinase activities, thereby activating downstream YAP and promoting cell growth. Co-crystal structure confirmed XMU-MP-1 binds on-target to MST1/2. XMU-MP-1 augments intestinal and liver repair/regeneration in mouse models.","method":"ELISA-based high-throughput biochemical kinase assay, co-crystal structure of XMU-MP-1 with MST1/2, structure-activity relationship, in vivo pharmacokinetics, mouse injury models","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 1 / Strong — co-crystal structure confirming on-target binding, in vitro kinase assay, in vivo pharmacodynamics, multiple orthogonal methods","pmids":["27535619"],"is_preprint":false},{"year":2016,"finding":"Mst1 kinase phosphorylates the actin-bundling protein L-plastin (LPL) at Thr89 in vitro, and Mst1 interacts with LPL in cells. Mutation of Thr89 to Ala impairs LPL localization to lamellipodia and fails to restore T cell migration in LPL-deficient cells or rescue thymic egress in bone marrow chimeras.","method":"In vitro kinase assay (MST1 phosphorylation of LPL at T89), co-immunoprecipitation, T89A mutant expression, T cell migration assays, bone marrow chimeras","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro kinase assay with site identification, T89A non-phosphorylatable mutant functional analysis, Co-IP; multiple orthogonal methods","pmids":["27465533"],"is_preprint":false},{"year":2017,"finding":"Rassf1A and Rassf5 modulate MST1 activity via SARAH domain heterodimerization; the MST1 N-terminal kinase domain also plays a role in stabilizing the complex beyond SARAH-SARAH interaction. Rassf-MST1 complex positively regulates MST1-H2B Ser14 phosphorylation (chromatin condensation marker) while suppressing MST1-FoxO phosphorylation.","method":"Surface plasmon resonance (domain mapping), in vitro kinase assays (H2B and FoxO phosphorylation by MST1 in presence/absence of Rassf), domain deletion/mutagenesis","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — SPR binding assays and in vitro kinase assays with multiple substrates; single lab","pmids":["28327630"],"is_preprint":false},{"year":2018,"finding":"MST1 is a component of the TNFα receptor 1 signaling complex (TNF-RSC). TNFα induces MST1 recruitment to TNF-RSC and interaction with HOIP (catalytic LUBAC component). Activated MST1 phosphorylates HOIP, inhibiting LUBAC-dependent linear ubiquitination of NEMO/IKKγ, thereby attenuating TNFα-induced NF-κB signaling. MST1 genetic ablation potentiates IKK activity and NF-κB target gene expression.","method":"Co-immunoprecipitation of MST1 with TNF-RSC, in vitro kinase assay (MST1 phosphorylation of HOIP), LUBAC ubiquitination assay, MST1 KO MEFs and macrophages, NF-κB reporter and cytokine assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vitro kinase assay, ubiquitination assay, Co-IP, clean KO with NF-κB pathway readout; multiple orthogonal methods","pmids":["30901564"],"is_preprint":false},{"year":2018,"finding":"MST1/2 act as signal-dependent amplifiers of IL-2-STAT5 activity in regulatory T cells. Unbiased quantitative proteomics revealed MST1 association with the cytoskeletal DOCK8-LRCHs module. MST1 deficiency limits Treg cell migration, access to IL-2, and activity of the small GTPase Rac, which mediates downstream STAT5 activation.","method":"Conditional Mst1/Mst2 KO in Treg cells, quantitative proteomics (AP-MS), Rac GTPase activity assay, STAT5 phosphorylation assay, Treg migration assays, IL-2 signaling assays","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with defined molecular (Rac, STAT5) and cellular (migration, suppression) phenotypes, proteomics-identified DOCK8-LRCHs interaction, multiple orthogonal methods","pmids":["30413360"],"is_preprint":false},{"year":2019,"finding":"MST1 directly phosphorylates and binds the netrin receptor UNC5B at Thr428, promoting its apoptotic activation and dopaminergic neuronal loss in the context of Netrin1 reduction. MST1 activation by Netrin1 deprivation diminishes YAP levels and increases cell death. Knockout of UNC5B abolishes netrin depletion-induced dopaminergic loss; blockade of MST1-UNC5B phosphorylation suppresses neuronal apoptosis.","method":"In vitro kinase assay (MST1 phosphorylation of UNC5B at T428), co-immunoprecipitation (MST1-UNC5B), UNC5B knockout, phospho-specific antibody, dopaminergic neuron apoptosis assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro kinase assay with site identification, phospho-specific detection, KO rescue, Co-IP; multiple orthogonal methods in single study","pmids":["32929029"],"is_preprint":false},{"year":2019,"finding":"MST1 directly phosphorylates Nur77 (nuclear receptor) at Thr366, promoting Nur77 transcriptional activity and upregulating downstream β3-integrin expression to improve endometrial receptivity. Endometrial phospho-Nur77 (T366) level is decreased in women with recurrent implantation failure.","method":"In vitro kinase assay followed by LC-MS/MS (identification of T366 phosphorylation site), phos-tag SDS-PAGE, phospho-specific antibody, luciferase transcriptional assay, embryo adhesion assay, delayed implantation mouse model","journal":"EBioMedicine","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with MS-based site identification, multiple functional readouts (transcription, embryo adhesion, in vivo implantation), single lab","pmids":["36623453"],"is_preprint":false},{"year":2019,"finding":"Gemcitabine activates MST1 through ROS production in pancreatic cancer cells; activated MST1 translocates to mitochondria and forms a complex with cyclophilin D (Cyp-D). MST1/Cyp-D mitochondrial complexation is required for gemcitabine-induced cell death; cyclosporin A (Cyp-D inhibitor) prevents this complexation and cell death.","method":"Co-immunoprecipitation (MST1-CypD), mitochondrial fractionation, ROS assay, shRNA silencing of MST1/CypD, cyclosporin A treatment, cell death assays","journal":"Biochimie","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP, fractionation, pharmacological inhibition, and RNAi; single lab with multiple orthogonal methods","pmids":["24732633"],"is_preprint":false},{"year":2009,"finding":"Akt phosphorylates MST1 at Thr120, inhibiting MST1 kinase activity, nuclear translocation, and autophosphorylation at Thr183. Phospho-T120 MST1 fails to activate downstream FOXO3a and JNK. An inverse correlation between pMST1-T120 and pMST1-T183 is observed in human ovarian tumors.","method":"In vitro kinase assay (Akt phosphorylation of MST1 at T120), T120 mutant analysis, Akt-MST1 co-immunoprecipitation, nuclear translocation assay, FOXO3a/JNK activation assays, human tumor analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro kinase assay with site identification, Co-IP, mutagenesis, multiple downstream readouts in single focused study","pmids":["19940129"],"is_preprint":false},{"year":2021,"finding":"TRAF6 mediates LPS-induced ubiquitination of MST1/STK4 in macrophages, resulting in negative feedback regulation. MST1 inhibits TRAF6 autoubiquitination and TRAF6-mediated downstream NF-κB signaling. Myeloid-specific MST1 ablation enhances NF-κB activation and proinflammatory cytokine production after LPS, and increases susceptibility to LPS-induced septic shock.","method":"Myeloid-specific MST1 KO mice, ubiquitination assays, TRAF6 autoubiquitination assay, co-immunoprecipitation, NF-κB reporter, cytokine measurement, septic shock model","journal":"Cellular and molecular life sciences : CMLS","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean myeloid KO with defined molecular and in vivo phenotypes, ubiquitination and signaling assays; multiple orthogonal methods","pmids":["32975614"],"is_preprint":false},{"year":2022,"finding":"MST1 directly phosphorylates p53, promoting neuronal apoptosis and Alzheimer's disease-like cognitive deficits. MST1 associates with p53; p53 knockout largely reverses MST1-induced AD-like cognitive deficits.","method":"Co-immunoprecipitation (MST1-p53), MST1 overexpression in normal and 5xFAD mice, p53 knockout rescue, cognitive and synaptic plasticity assays","journal":"Progress in neurobiology","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP, genetic epistasis (p53 KO rescue), MST1 overexpression phenotype; single lab, phosphorylation site not formally mapped in abstract","pmids":["35525373"],"is_preprint":false},{"year":2022,"finding":"MST1 phosphorylates Cx43 (connexin 43) at Ser255 in endothelial cells; this phosphorylation closes Cx43 hemichannels and prevents EC activation. Oscillatory shear stress inhibits MST1 phosphorylation, leading to reduced pCx43-S255, Cx43 hemichannel opening (mediated by Filamin B-dependent translocation of Cx43 to lipid rafts), EC activation, and atherosclerosis.","method":"Mass spectrometry (substrate identification), Co-IP, proximity ligation assay, dye uptake assay (hemichannel function), lentiviral MST1/Cx43-S255 overexpression, EC-specific Mst1-KO/ApoE mice in carotid ligation atherosclerosis model","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — MS substrate identification, hemichannel functional assay, phosphomimetic rescue in vivo, multiple orthogonal methods in single focused study","pmids":["36164986"],"is_preprint":false},{"year":2019,"finding":"MST1 suppresses pancreatic cancer via ROS-induced caspase-1-dependent pyroptosis. This mechanism is independent of the Hippo/YAP pathway; ROS scavenger N-acetylcysteine attenuates MST1-induced caspase-1 activation and cell death.","method":"MST1 overexpression in PDAC cells, caspase-1 activity assay, ROS measurement, N-acetylcysteine rescue, cell death/proliferation/migration/invasion assays, YAP pathway epistasis","journal":"Molecular cancer research : MCR","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — functional assays with pharmacological rescue and pathway epistasis, single lab, mechanism not fully reconstituted in vitro","pmids":["30796177"],"is_preprint":false},{"year":2016,"finding":"MST1 negatively regulates Hippo signaling in dendritic cells through the p38 MAPK pathway: MST1 deficiency in DCs increases p38 MAPK activation, leading to increased IL-6 secretion and subsequent STAT3 activation in CD4+ T cells, promoting Th17 differentiation.","method":"DC-specific MST1 KO/overexpression, p38 MAPK activation assay, IL-6 ELISA, STAT3 activation assay, Th17 differentiation assay, EAE model","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — DC-specific KO with defined molecular pathway (p38-IL6-STAT3) and in vivo phenotype; single lab","pmids":["28145433"],"is_preprint":false},{"year":2019,"finding":"FGFR4 phosphorylates MST1 at Tyr433 in a kinase activity-dependent manner (confirmed by mass spectrometry). Y433F mutation in MST1 induces MST1 activation (increased Thr phosphorylation of MST1/2 and MOB1). FGFR4 inhibition leads to increased MST1/2 activation, enhanced MST1 nuclear localization, and generation of cleaved/autophosphorylated MST1, and apoptosis.","method":"Kinase substrate screen, mass spectrometry (Y433 phosphorylation), Y433F mutagenesis, MST1/2/MOB1 phosphorylation assays, FGFR4 knockdown/inhibition, nuclear localization imaging","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 1 / Moderate — MS-confirmed phosphorylation site, mutagenesis, kinase activity readouts, multiple orthogonal methods in single study","pmids":["30903103"],"is_preprint":false},{"year":2024,"finding":"SIRT7 suppresses MST1 through dual mechanisms: (1) transcriptional repression by binding the MST1 promoter and inducing H3K18 deacetylation, and (2) direct binding and deacetylation of MST1 protein, priming acetylation-dependent MST1 ubiquitination and proteasomal degradation. MST1 reduction promotes YAP nuclear localization and transcriptional activation in liver cancer.","method":"ChIP (SIRT7 on MST1 promoter, H3K18ac), co-immunoprecipitation (SIRT7-MST1), mass spectrometry (MST1 deacetylation sites), ubiquitination assay, luciferase (MST1 promoter activity), YAP nuclear localization assay, xenograft mouse model","journal":"Cancer science","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP, MS-confirmed deacetylation, ubiquitination assay, Co-IP, multiple orthogonal methods in single focused study","pmids":["38288904"],"is_preprint":false},{"year":2021,"finding":"USP46 directly binds MST1 and decreases its ubiquitination (stabilizes MST1 protein), thereby potentiating MST1 kinase activity to suppress YAP1 and HCC progression.","method":"Co-immunoprecipitation (USP46-MST1), ubiquitination assay, MST1 protein stability assay, YAP1 activity assay, HCC cell proliferation/invasion, in vivo xenograft","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP, ubiquitination assay, functional rescue; single lab","pmids":["34029571"],"is_preprint":false},{"year":2016,"finding":"MST1 promotes Sirt1 stability by inhibiting Sirt1 ubiquitination in hepatocytes. Mst1-/- mice show impaired fasting-induced hepatic Sirt1 expression. MST1 overexpression inhibits Srebp-1c expression and increases antioxidant gene expression in primary hepatocytes.","method":"Mst1 knockout mice (fasting/HFD model), ubiquitination assay for Sirt1, Sirt1 and Srebp-1c western blot in primary hepatocytes with MST1 overexpression","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Sirt1 ubiquitination assay, KO mice with molecular readout; single lab, mechanistic link not fully reconstituted","pmids":["26903296"],"is_preprint":false},{"year":2016,"finding":"Mst1 regulates MST1-mediated endothelial tip cell polarity and sprouting angiogenesis via a ROS-MST1-FOXO1 cascade. Hypoxia activates MST1 through mitochondrial ROS; activated MST1 promotes FOXO1 nuclear import, augmenting transcription of polarity and migration-associated genes.","method":"Endothelial-specific MST1 or FOXO1 deletion mice, ROS measurement, MST1 kinase activation assay, FOXO1 nuclear translocation imaging, sprouting angiogenesis (retinal and OIR models)","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — endothelial-specific KO of MST1 and FOXO1, defined molecular (ROS, FOXO1 nuclear import) and in vivo vascular phenotypes, multiple orthogonal methods","pmids":["30783090"],"is_preprint":false}],"current_model":"MST1 (STK4) is a Ste20-family serine/threonine kinase that homodimerizes via a C-terminal SARAH domain (activating intermolecular autophosphorylation at Thr183/Thr187) and is held inactive by a central inhibitory domain; it is activated by caspase-3 cleavage (releasing the kinase domain to the nucleus where it phosphorylates histone H2B and promotes chromatin condensation), by intermolecular transphosphorylation, and by upstream kinases c-Abl (pY433) while being negatively regulated by Akt (pT120), mTORC2 (pS438), and FGFR4 (pY433); its major physiological substrates include MOB1/MOBKL1 (activating LATS1/2 to phosphorylate and inactivate YAP1), FOXO1/3 (promoting nuclear entry and apoptotic transcription), Bcl-xL (pS14, antagonizing Bax binding), PDX1 (pT11, triggering proteasomal degradation), IRF3 (pT75/T253, suppressing antiviral signaling), Aurora B (inhibiting kinetochore-microtubule destabilization), HOIP/LUBAC (attenuating NF-κB), AURKA (promoting ciliogenesis), L-plastin (pT89, directing T cell migration), Cx43 (pS255, closing hemichannels), Nur77 (pT366, promoting endometrial receptivity), and UNC5B (pT428, promoting apoptosis); it interacts with scaffold proteins RASSF1/Nore1 (via SARAH domains), SAV1, and DOCK8, and can be stabilized or degraded via ubiquitination controlled by USP46 and SIRT7/TRAF6, respectively, placing MST1 as a central integrator of the Hippo tumor-suppressor cascade, apoptosis, immune cell trafficking, mitochondrial homeostasis, and antiviral defense."},"narrative":{"mechanistic_narrative":"MST1 (STK4) is a Ste20-family serine/threonine kinase that serves as a central integrator of growth-suppressive, apoptotic, and immune-regulatory signaling, most prominently as the apical kinase of the Hippo tumor-suppressor cascade [PMID:19878874, PMID:20080598]. The kinase homodimerizes through its extreme C-terminal SARAH domain and is held in check by a central inhibitory region; full activation requires intermolecular autophosphorylation of the activation loop at Thr183/Thr187, which is potentiated by dimerization [PMID:8702870, PMID:12223493]. A second, irreversible activation route is caspase-3 cleavage, which excises the C-terminal regulatory domain bearing nuclear export signals, freeing the kinase domain to enter the nucleus, phosphorylate histones, and drive chromatin condensation and apoptosis [PMID:9545236, PMID:11517310]. In the Hippo pathway, MST1 phosphorylates MOB1/MOBKL1, which licenses LATS-mediated inactivating phosphorylation of YAP, restraining proliferation and tumorigenesis in liver and other tissues [PMID:18328708, PMID:19878874]. Beyond Hippo, MST1 phosphorylates a broad substrate set to enforce apoptosis and cellular homeostasis, including FOXO1/3 (disrupting 14-3-3 binding to drive nuclear import and death) [PMID:19221179], Bcl-xL at a mitochondrial complex [PMID:24813943], PDX1 (triggering its degradation in beta cells) [PMID:24633305], Aurora B (ensuring accurate kinetochore-microtubule attachment) [PMID:20171103], AURKA (promoting ciliogenesis) [PMID:25367221], and the antiviral factor IRF3 and the LUBAC component HOIP (both attenuating innate-immune transcriptional output) [PMID:27125670, PMID:30901564]. In lymphocytes and myeloid cells MST1 governs adhesion, trafficking, and effector function largely through MOB1-DOCK8-Rac/RhoA signaling and cytoskeletal substrates such as L-plastin [PMID:19073936, PMID:19339990, PMID:22412158, PMID:27465533, PMID:30413360]. MST1 activity is tuned by an extensive regulatory network: it is inhibited by Akt (Thr120), mTORC2 (Ser438), and FGFR4 (Tyr433), activated by c-Abl (Tyr433) and the phosphatase PHLPP (removing inhibitory Thr387), and its protein level is set by opposing ubiquitin machineries stabilized by USP46 and degraded via SIRT7/TRAF6 [PMID:20513427, PMID:21715626, PMID:25843706, PMID:19940129, PMID:30903103, PMID:38288904, PMID:34029571]. Scaffold proteins of the RASSF/Nore1 family and SAV1 bind MST1 via SARAH domains and bias its substrate selectivity [PMID:16757333, PMID:28327630].","teleology":[{"year":1996,"claim":"Established the autoregulatory architecture of MST1 — how a constitutively folded kinase keeps itself off — by mapping a C-terminal dimerization module and a separable central inhibitory domain.","evidence":"Deletion mutagenesis with Co-IP, yeast two-hybrid, cross-linking, and size exclusion chromatography","pmids":["8702870"],"confidence":"High","gaps":["Did not identify the physiological trigger that relieves inhibition","No structure of the autoinhibited dimer"]},{"year":1998,"claim":"Defined caspase-3 cleavage as an apoptotic activation switch, showing MST1 is both an effector and amplifier of cell death through a caspase feedback loop and stress-kinase activation.","evidence":"Caspase inhibitor pharmacology, in vivo cleavage assays, and kinase-dead/truncation overexpression during Fas and staurosporine apoptosis","pmids":["9545236"],"confidence":"High","gaps":["Did not resolve whether cleavage is required versus sufficient for physiological apoptosis","Downstream substrates of nuclear MST1 not yet identified"]},{"year":2001,"claim":"Explained how cleavage couples to function spatially: removal of the C-terminal NES-bearing fragment relocalizes the kinase to the nucleus, linking cleavage to chromatin condensation.","evidence":"NES mutagenesis, leptomycin B export inhibition, and subcellular fractionation in apoptotic cells (PNAS); JNK-dependence and CAD-mediated DNA fragmentation epistasis (Genes Cells)","pmids":["11517310","11442632"],"confidence":"High","gaps":["Nuclear substrates driving condensation not defined","Relative contribution of caspase-dependent versus JNK arms left unquantified"]},{"year":2002,"claim":"Mapped the activating phosphorylation code (Thr183/Thr187 by dimerization-enhanced intermolecular autophosphorylation) and identified the first direct binding partner augmenting apoptosis.","evidence":"Site-directed mutagenesis with in vitro kinase and detachment/apoptosis assays (JBC); DAP4 Co-IP and p53-dependence (JBC)","pmids":["12223493","12384512"],"confidence":"High","gaps":["Upstream kinase versus pure autophosphorylation contributions unresolved","DAP4 link to p53 functional consequence inferred, not reconstituted"]},{"year":2006,"claim":"Reconstituted spontaneous dimer autoactivation in vitro and showed RASSF/Nore1 scaffolds act through the SARAH domain to control activation, establishing membrane recruitment as an activating context.","evidence":"In vitro kinase reconstitution, SARAH binding assays, and membrane/Ras recruitment experiments","pmids":["16757333"],"confidence":"Medium","gaps":["Methods-paper format limits independent functional follow-up","Direction of RASSF effect (inhibit vs. recruit-activate) context-dependent and unresolved"]},{"year":2007,"claim":"Positioned MST1 in reciprocal antagonism with Akt, identifying it as a lipid-raft Akt1 interactor and inhibitor relevant to survival signaling.","evidence":"Co-IP from lipid raft fractions, endogenous kinase activity assays, and zebrafish rescue of membrane-Akt1 lethality","pmids":["17932490"],"confidence":"Medium","gaps":["Mechanism of Akt inhibition (catalytic vs. sequestration) not defined","Reciprocal Akt-on-MST1 regulation addressed only later"]},{"year":2008,"claim":"Identified MOB1/MOBKL1 as the direct substrate connecting MST1 to LATS activation, anchoring MST1 as an apical Hippo kinase controlling cell-cycle progression.","evidence":"In vitro kinase assays, MST-dependent cellular phosphorylation, and non-phosphorylatable MOB knock-in with cell-cycle analysis","pmids":["18328708"],"confidence":"High","gaps":["Did not establish in vivo organ-size relevance (addressed in genetic models)","Mitotic activation trigger upstream of MST1 unclear"]},{"year":2009,"claim":"Genetic loss-of-function across multiple systems revealed MST1's physiological roles: T-cell proliferation/adhesion control, neuronal FOXO1-dependent death, and bona fide liver tumor suppression via YAP inactivation.","evidence":"MST1-knockout T cells with substrate phosphorylation and adhesion assays (PNAS, EMBO J); FOXO1 Ser212 phosphorylation and 14-3-3 dissociation in neurons (JBC); conditional liver Mst1/2 KO with YAP Ser127 and HCC rescue (Cancer Cell); Akt phosphorylation of MST1 Thr120 (JBC)","pmids":["19073936","19339990","19221179","19878874","19940129"],"confidence":"High","gaps":["Liver YAP regulation attributed to a LATS-distinct intermediary kinase not identified","Tissue-specific substrate selection mechanisms unresolved"]},{"year":2010,"claim":"Solidified MST1/2 redundancy in organ-size/tumor control and expanded the substrate repertoire to mitotic fidelity (Aurora B) and apoptotic transcription (Sirt1-p53), while defining the PHLPP/Akt/Thr387 activity rheostat.","evidence":"Mst1/2 double-KO mice with YAP and TNFα-apoptosis readouts (PNAS); MST1 RNAi with in vitro Aurora B phosphorylation and checkpoint rescue (Curr Biol); PHLPP phosphatase and Akt Thr387 kinase assays (Mol Cell); MST1-Sirt1-p53 kinase and acetylation assays (JBC)","pmids":["20080598","20171103","20513427","21212262"],"confidence":"High","gaps":["Integration of mitotic versus Hippo roles in vivo not dissected","Sirt1-p53 axis confidence medium and not validated in knockout"]},{"year":2011,"claim":"Defined tyrosine-kinase inputs and ubiquitin-dependent stability control, showing c-Abl phosphorylation at Tyr433 stabilizes and activates MST1 to drive FOXO3-dependent neuronal death under oxidative stress.","evidence":"In vitro c-Abl kinase assay, CHIP ubiquitination assay, and MST1-FOXO3 Co-IP in primary neurons","pmids":["21715626"],"confidence":"High","gaps":["Interplay between Tyr433 and the later-defined FGFR4 phosphorylation at the same residue unaddressed","CHIP versus other E3 ligase contributions not delineated"]},{"year":2012,"claim":"Mechanistically linked MST1 to immune-cell motility by showing phospho-MOB1 recruits the Rac GEF DOCK8, activating Rac1/RhoA to drive thymic egress and migration.","evidence":"Mst1/2 double-KO thymocytes with GTP-charging assays and phospho-Mob1/DOCK8 Co-IP","pmids":["22412158"],"confidence":"High","gaps":["How a Hippo-core substrate (MOB1) is rewired to cytoskeletal output is not structurally explained"]},{"year":2014,"claim":"Extended direct substrate phosphorylation to metabolic and cardiac contexts — PDX1 degradation in beta cells, Bcl-xL Ser14 at mitochondria — and identified the basal-body/AURKA ciliogenesis function.","evidence":"In vitro kinase assays with site mapping plus KO/transgenic mice (Nat Med, PDX1); mitochondrial K-Ras/RASSF1A/Mst1 complex and Bcl-xL assays (Mol Cell); AURKA phosphorylation and ciliogenesis in cells/zebrafish (Nat Commun)","pmids":["24633305","24813943","25367221"],"confidence":"High","gaps":["Determinants of substrate choice across these contexts not defined","Relationship of ciliary AURKA role to mitotic AURKA role unaddressed"]},{"year":2015,"claim":"Defined mTORC2 as a direct negative regulator phosphorylating Ser438 to block dimerization, and assigned MST1/2 a role in innate immunity by directing mitochondrial recruitment to phagosomes.","evidence":"In vitro mTORC2 kinase assay with S438 mutagenesis and cardiac Rictor KO (Cell Rep); Mst1/2-KO macrophages with Rac activation, TRAF6-ECSIT Co-IP, and ROS/bactericidal assays (Nat Immunol)","pmids":["25843706","26414765"],"confidence":"High","gaps":["How a SARAH-domain phosphorylation mechanistically disrupts dimer interface not structurally resolved"]},{"year":2016,"claim":"Established MST1 as a brake on innate antiviral signaling (IRF3) and on NF-κB-promoting Th17 responses, and revealed scaffold (DLG5)- and heterodimerization-based mechanisms that suppress MST1 kinase output; also delivered a structurally validated chemical probe (XMU-MP-1) and additional substrates (L-plastin).","evidence":"MST1-IRF3 kinase/dimerization assays and KO viral challenge (Genes Dev); DLG5 AP-MS with genetic rescue (Genes Dev); Mst1/Mst2 heterodimer Co-IP and kinase comparison (Curr Biol); XMU-MP-1 co-crystal and regeneration models (Sci Transl Med); L-plastin Thr89 kinase assay (J Immunol); DC-specific MST1 KO p38-IL6-STAT3 axis (Nat Commun); hepatic Sirt1 stabilization in KO mice (BBRC)","pmids":["27125670","28087714","27238285","27535619","27465533","28145433","26903296"],"confidence":"High","gaps":["MST2-specific divergence from MST1 (e.g., IRF3) mechanistically unexplained","Whether scaffold-based inhibition operates in all tissues unresolved"]},{"year":2017,"claim":"Showed RASSF SARAH heterodimerization biases MST1 substrate selectivity — promoting H2B but suppressing FoxO phosphorylation — providing a mechanism for context-specific output, and added the angiogenic ROS-MST1-FOXO1 endothelial cascade.","evidence":"SPR domain mapping with in vitro multi-substrate kinase assays (Sci Rep); endothelial-specific MST1/FOXO1 KO with sprouting angiogenesis models (Nat Commun)","pmids":["28327630","30783090"],"confidence":"Medium","gaps":["Structural basis for scaffold-directed substrate switching not determined","RASSF effects assayed only in vitro for substrate selectivity"]},{"year":2018,"claim":"Placed MST1 inside the TNF receptor signaling complex as a HOIP/LUBAC-phosphorylating brake on NF-κB, defining a direct non-Hippo immune-regulatory mechanism.","evidence":"MST1-TNF-RSC Co-IP, in vitro HOIP kinase assay, LUBAC ubiquitination assay, and MST1-KO NF-κB readouts; Treg DOCK8-LRCHs proteomics and Rac/STAT5 assays (Immunity)","pmids":["30901564","30413360"],"confidence":"High","gaps":["How catalytic activity is engaged within the TNF-RSC not detailed","Coordination of MST1 immune-regulatory roles with its Hippo role unresolved"]},{"year":2019,"claim":"Expanded the direct-substrate map into neuronal (UNC5B, p53), reproductive (Nur77), and identified additional negative regulation by FGFR4 at Tyr433, plus Hippo-independent ROS-pyroptosis tumor suppression.","evidence":"In vitro kinase assays with site mapping and KO/rescue for UNC5B Thr428 (PNAS) and Nur77 Thr366 (EBioMedicine); FGFR4 MS-confirmed Tyr433 phosphorylation and mutagenesis (Cell Death Differ); MST1 overexpression caspase-1 pyroptosis with NAC rescue (Mol Cancer Res)","pmids":["32929029","36623453","30903103","30796177"],"confidence":"High","gaps":["FGFR4 and c-Abl both target Tyr433 with opposite outcomes — reconciliation unresolved","Pyroptosis mechanism medium-confidence, not reconstituted in vitro"]},{"year":2021,"claim":"Resolved opposing ubiquitin-dependent control of MST1 abundance, with USP46 stabilizing MST1 to enforce YAP suppression and TRAF6 mediating LPS-induced MST1 ubiquitination in a reciprocal NF-κB feedback loop.","evidence":"USP46-MST1 Co-IP and ubiquitination/stability assays with HCC models (Exp Cell Res); myeloid-specific MST1 KO with TRAF6 autoubiquitination assays and septic-shock model (CMLS)","pmids":["34029571","32975614"],"confidence":"Medium","gaps":["E3 ligase(s) opposed by USP46 not identified","Whether USP46 and TRAF6 act on the same MST1 pool unaddressed"]},{"year":2022,"claim":"Added cardiovascular (Cx43 Ser255 hemichannel closure) and neurodegenerative (p53-dependent AD-like deficits) functions, broadening MST1's role in endothelial activation and cognition.","evidence":"MS substrate identification with hemichannel dye-uptake assay and EC-specific Mst1-KO atherosclerosis model (Circ Res); MST1-p53 Co-IP and p53-KO rescue in 5xFAD mice (Prog Neurobiol)","pmids":["36164986","35525373"],"confidence":"Medium","gaps":["p53 phosphorylation site not formally mapped","Mechanistic overlap with earlier MST1-Sirt1-p53 axis not integrated"]},{"year":2024,"claim":"Defined transcriptional plus post-translational suppression of MST1 by SIRT7, linking deacetylase activity to MST1 promoter repression and acetylation-primed degradation that releases YAP in liver cancer.","evidence":"ChIP for SIRT7/H3K18ac on the MST1 promoter, SIRT7-MST1 Co-IP, MS deacetylation site mapping, ubiquitination assay, and xenograft model","pmids":["38288904"],"confidence":"High","gaps":["The acetylation-dependent E3 ligase not identified","Relationship between SIRT7 and USP46/TRAF6 control of MST1 unresolved"]},{"year":null,"claim":"It remains unresolved how MST1 selects among its many divergent substrates and reconciles opposing inputs converging on shared residues (e.g., c-Abl versus FGFR4 at Tyr433), and how scaffold context dictates whether MST1 drives Hippo, apoptotic, or immune-regulatory outputs.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of substrate-selecting MST1 complexes","No unified framework integrating tissue-specific scaffolds with substrate choice","Convergence of opposing tyrosine-kinase inputs at Tyr433 mechanistically unexplained"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[4,8,10,14,19,20,21,24,28,30,32,33,38]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[4,8,24,30]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[33]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2,7]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,10,24]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[20,22,34]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[21]}],"pathway":[{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[8,11,13,14]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[1,3,19,20,32]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[9,24,30,31,36,40]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[11,15,23,35]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[21,45]}],"complexes":["TNF receptor signaling complex (TNF-RSC)","MST1/2-SAV1 complex","K-Ras/RASSF1A/MST1 mitochondrial complex"],"partners":["MOB1","RASSF1","SAV1","DOCK8","AKT1","HOIP","AURKB","USP46"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P26927","full_name":"Hepatocyte growth factor-like protein","aliases":["Macrophage stimulatory protein","Macrophage-stimulating protein","MSP"],"length_aa":711,"mass_kda":80.3,"function":"","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P26927/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MST1","classification":"Not Classified","n_dependent_lines":5,"n_total_lines":383,"dependency_fraction":0.013054830287206266},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MST1","total_profiled":1310},"omim":[{"mim_id":"620929","title":"MOB KINASE ACTIVATOR 3A; MOB3A","url":"https://www.omim.org/entry/620929"},{"mim_id":"620808","title":"SMALL NUCLEOLAR RNA HOST GENE 17; SNHG17","url":"https://www.omim.org/entry/620808"},{"mim_id":"620110","title":"WW AND C2 DOMAINS-CONTAINING PROTEIN 2; WWC2","url":"https://www.omim.org/entry/620110"},{"mim_id":"617919","title":"STRIATIN-INTERACTING PROTEIN 2; STRIP2","url":"https://www.omim.org/entry/617919"},{"mim_id":"617918","title":"STRIATIN-INTERACTING PROTEIN 1; STRIP1","url":"https://www.omim.org/entry/617918"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"liver","ntpm":864.2}],"url":"https://www.proteinatlas.org/search/MST1"},"hgnc":{"alias_symbol":["MSP","NF15S2"],"prev_symbol":["D3F15S2","HGFL","DNF15S2"]},"alphafold":{"accession":"P26927","domains":[{"cath_id":"3.50.4.10","chopping":"23-107","consensus_level":"high","plddt":86.4128,"start":23,"end":107},{"cath_id":"2.40.10.10","chopping":"485-711","consensus_level":"medium","plddt":84.4473,"start":485,"end":711}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P26927","model_url":"https://alphafold.ebi.ac.uk/files/AF-P26927-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P26927-F1-predicted_aligned_error_v6.png","plddt_mean":85.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MST1","jax_strain_url":"https://www.jax.org/strain/search?query=MST1"},"sequence":{"accession":"P26927","fasta_url":"https://rest.uniprot.org/uniprotkb/P26927.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P26927/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P26927"}},"corpus_meta":[{"pmid":"19878874","id":"PMC_19878874","title":"Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.","date":"2009","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/19878874","citation_count":796,"is_preprint":false},{"pmid":"20080598","id":"PMC_20080598","title":"Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20080598","citation_count":474,"is_preprint":false},{"pmid":"18328708","id":"PMC_18328708","title":"MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation.","date":"2008","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/18328708","citation_count":359,"is_preprint":false},{"pmid":"27535619","id":"PMC_27535619","title":"Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration.","date":"2016","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27535619","citation_count":332,"is_preprint":false},{"pmid":"9545236","id":"PMC_9545236","title":"Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9545236","citation_count":331,"is_preprint":false},{"pmid":"26414765","id":"PMC_26414765","title":"Kinases Mst1 and Mst2 positively regulate phagocytic induction of reactive oxygen species and bactericidal activity.","date":"2015","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26414765","citation_count":212,"is_preprint":false},{"pmid":"8702870","id":"PMC_8702870","title":"The Ste20-like protein kinase, Mst1, dimerizes and contains an inhibitory domain.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8702870","citation_count":193,"is_preprint":false},{"pmid":"24633305","id":"PMC_24633305","title":"MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes.","date":"2014","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24633305","citation_count":182,"is_preprint":false},{"pmid":"12223493","id":"PMC_12223493","title":"Mapping of MST1 kinase sites of phosphorylation. Activation and autophosphorylation.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12223493","citation_count":164,"is_preprint":false},{"pmid":"19221179","id":"PMC_19221179","title":"Regulation of neuronal cell death by MST1-FOXO1 signaling.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19221179","citation_count":160,"is_preprint":false},{"pmid":"31816893","id":"PMC_31816893","title":"Quercetin Suppresses the Progression of Atherosclerosis by Regulating MST1-Mediated Autophagy in ox-LDL-Induced RAW264.7 Macrophage Foam Cells.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31816893","citation_count":151,"is_preprint":false},{"pmid":"28480597","id":"PMC_28480597","title":"Melatonin protects against diabetic cardiomyopathy through Mst1/Sirt3 signaling.","date":"2017","source":"Journal of pineal research","url":"https://pubmed.ncbi.nlm.nih.gov/28480597","citation_count":151,"is_preprint":false},{"pmid":"11517310","id":"PMC_11517310","title":"Caspase cleavage of MST1 promotes nuclear translocation and chromatin condensation.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11517310","citation_count":147,"is_preprint":false},{"pmid":"22412158","id":"PMC_22412158","title":"The Mst1 and Mst2 kinases control activation of rho family GTPases and thymic egress of mature thymocytes.","date":"2012","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22412158","citation_count":142,"is_preprint":false},{"pmid":"19339990","id":"PMC_19339990","title":"Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19339990","citation_count":140,"is_preprint":false},{"pmid":"19073936","id":"PMC_19073936","title":"The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19073936","citation_count":134,"is_preprint":false},{"pmid":"24813943","id":"PMC_24813943","title":"Mst1 promotes cardiac myocyte apoptosis through phosphorylation and inhibition of Bcl-xL.","date":"2014","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/24813943","citation_count":124,"is_preprint":false},{"pmid":"17932490","id":"PMC_17932490","title":"The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1.","date":"2007","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17932490","citation_count":118,"is_preprint":false},{"pmid":"30708325","id":"PMC_30708325","title":"Mst1 inhibition attenuates non-alcoholic fatty liver disease via reversing Parkin-related mitophagy.","date":"2019","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/30708325","citation_count":117,"is_preprint":false},{"pmid":"25843706","id":"PMC_25843706","title":"mTORC2 regulates cardiac response to stress by inhibiting MST1.","date":"2015","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/25843706","citation_count":116,"is_preprint":false},{"pmid":"19786569","id":"PMC_19786569","title":"Crucial role for Mst1 and Mst2 kinases in early embryonic development of the mouse.","date":"2009","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19786569","citation_count":115,"is_preprint":false},{"pmid":"21715626","id":"PMC_21715626","title":"The c-Abl-MST1 signaling pathway mediates oxidative stress-induced neuronal cell death.","date":"2011","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21715626","citation_count":111,"is_preprint":false},{"pmid":"30796177","id":"PMC_30796177","title":"MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis.","date":"2019","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/30796177","citation_count":110,"is_preprint":false},{"pmid":"27510910","id":"PMC_27510910","title":"MST1 coordinately regulates autophagy and apoptosis in diabetic cardiomyopathy in mice.","date":"2016","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/27510910","citation_count":108,"is_preprint":false},{"pmid":"20513427","id":"PMC_20513427","title":"Mst1 is an interacting protein that mediates PHLPPs' induced apoptosis.","date":"2010","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/20513427","citation_count":107,"is_preprint":false},{"pmid":"29961191","id":"PMC_29961191","title":"Mst1 promotes cardiac ischemia-reperfusion injury by inhibiting the ERK-CREB pathway and repressing FUNDC1-mediated mitophagy.","date":"2018","source":"The journal of physiological sciences : JPS","url":"https://pubmed.ncbi.nlm.nih.gov/29961191","citation_count":104,"is_preprint":false},{"pmid":"11442632","id":"PMC_11442632","title":"MST1-JNK promotes apoptosis via caspase-dependent and independent pathways.","date":"2001","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/11442632","citation_count":104,"is_preprint":false},{"pmid":"30413360","id":"PMC_30413360","title":"Hippo Kinases Mst1 and Mst2 Sense and Amplify IL-2R-STAT5 Signaling in Regulatory T Cells to Establish Stable Regulatory Activity.","date":"2018","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/30413360","citation_count":99,"is_preprint":false},{"pmid":"21102585","id":"PMC_21102585","title":"Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development.","date":"2010","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21102585","citation_count":92,"is_preprint":false},{"pmid":"35525373","id":"PMC_35525373","title":"MST1 mediates neuronal loss and cognitive deficits: A novel therapeutic target for Alzheimer's disease.","date":"2022","source":"Progress in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/35525373","citation_count":84,"is_preprint":false},{"pmid":"29674007","id":"PMC_29674007","title":"Mst1 inhibits Sirt3 expression and contributes to diabetic cardiomyopathy through inhibiting Parkin-dependent mitophagy.","date":"2018","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/29674007","citation_count":83,"is_preprint":false},{"pmid":"21212262","id":"PMC_21212262","title":"MST1 promotes apoptosis through regulating Sirt1-dependent p53 deacetylation.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21212262","citation_count":83,"is_preprint":false},{"pmid":"23985272","id":"PMC_23985272","title":"Mst1 and Mst2 kinases: regulations and diseases.","date":"2013","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/23985272","citation_count":81,"is_preprint":false},{"pmid":"30251683","id":"PMC_30251683","title":"Exosomal Mst1 transfer from cardiac microvascular endothelial cells to cardiomyocytes deteriorates diabetic cardiomyopathy.","date":"2018","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/30251683","citation_count":79,"is_preprint":false},{"pmid":"12384512","id":"PMC_12384512","title":"Death-associated protein 4 binds MST1 and augments MST1-induced apoptosis.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12384512","citation_count":78,"is_preprint":false},{"pmid":"27618557","id":"PMC_27618557","title":"MST1/MST2 Protein Kinases: Regulation and Physiologic Roles.","date":"2016","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27618557","citation_count":76,"is_preprint":false},{"pmid":"27125670","id":"PMC_27125670","title":"Mst1 shuts off cytosolic antiviral defense through IRF3 phosphorylation.","date":"2016","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/27125670","citation_count":76,"is_preprint":false},{"pmid":"30783090","id":"PMC_30783090","title":"A MST1-FOXO1 cascade establishes endothelial tip cell polarity and facilitates sprouting angiogenesis.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30783090","citation_count":74,"is_preprint":false},{"pmid":"15007383","id":"PMC_15007383","title":"Nore1 inhibits tumor cell growth independent of Ras or the MST1/2 kinases.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15007383","citation_count":74,"is_preprint":false},{"pmid":"26721416","id":"PMC_26721416","title":"Hippo/MST1 signaling mediates microglial activation following acute cerebral ischemia-reperfusion injury.","date":"2015","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/26721416","citation_count":72,"is_preprint":false},{"pmid":"28145433","id":"PMC_28145433","title":"Dendritic cell MST1 inhibits Th17 differentiation.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28145433","citation_count":71,"is_preprint":false},{"pmid":"25367221","id":"PMC_25367221","title":"The MST1/2-SAV1 complex of the Hippo pathway promotes ciliogenesis.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25367221","citation_count":71,"is_preprint":false},{"pmid":"19079170","id":"PMC_19079170","title":"Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis.","date":"2008","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19079170","citation_count":70,"is_preprint":false},{"pmid":"19940129","id":"PMC_19940129","title":"Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19940129","citation_count":68,"is_preprint":false},{"pmid":"16757333","id":"PMC_16757333","title":"Nore1 and RASSF1 regulation of cell proliferation and of the MST1/2 kinases.","date":"2006","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/16757333","citation_count":67,"is_preprint":false},{"pmid":"28087714","id":"PMC_28087714","title":"DLG5 connects cell polarity and Hippo signaling protein networks by linking PAR-1 with MST1/2.","date":"2016","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/28087714","citation_count":65,"is_preprint":false},{"pmid":"29760744","id":"PMC_29760744","title":"Mst1 regulates post-infarction cardiac injury through the JNK-Drp1-mitochondrial fission pathway.","date":"2018","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/29760744","citation_count":55,"is_preprint":false},{"pmid":"30901564","id":"PMC_30901564","title":"MST1 Negatively Regulates TNFα-Induced NF-κB Signaling through Modulating LUBAC Activity.","date":"2019","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/30901564","citation_count":54,"is_preprint":false},{"pmid":"25912685","id":"PMC_25912685","title":"A conserved MST1/2-YAP axis mediates Hippo signaling during lung growth.","date":"2015","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/25912685","citation_count":54,"is_preprint":false},{"pmid":"33037981","id":"PMC_33037981","title":"Exosomal miR-199a-5p promotes hepatic lipid accumulation by modulating MST1 expression and fatty acid metabolism.","date":"2020","source":"Hepatology international","url":"https://pubmed.ncbi.nlm.nih.gov/33037981","citation_count":53,"is_preprint":false},{"pmid":"29632474","id":"PMC_29632474","title":"Melatonin Regulates Apoptosis and Autophagy Via ROS-MST1 Pathway in Subarachnoid Hemorrhage.","date":"2018","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/29632474","citation_count":52,"is_preprint":false},{"pmid":"27765911","id":"PMC_27765911","title":"Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27765911","citation_count":52,"is_preprint":false},{"pmid":"32253273","id":"PMC_32253273","title":"Tubule-Specific Mst1/2 Deficiency Induces CKD via YAP and Non-YAP Mechanisms.","date":"2020","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/32253273","citation_count":50,"is_preprint":false},{"pmid":"25373346","id":"PMC_25373346","title":"Mst1 regulates glioma cell proliferation via the AKT/mTOR signaling pathway.","date":"2014","source":"Journal of neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25373346","citation_count":49,"is_preprint":false},{"pmid":"30903103","id":"PMC_30903103","title":"FGFR4 phosphorylates MST1 to confer breast cancer cells resistance to MST1/2-dependent apoptosis.","date":"2019","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/30903103","citation_count":49,"is_preprint":false},{"pmid":"27053234","id":"PMC_27053234","title":"MST1: a promising therapeutic target to restore functional beta cell mass in diabetes.","date":"2016","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/27053234","citation_count":45,"is_preprint":false},{"pmid":"20171103","id":"PMC_20171103","title":"MST1 limits the kinase activity of aurora B to promote stable kinetochore-microtubule attachment.","date":"2010","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/20171103","citation_count":43,"is_preprint":false},{"pmid":"24852423","id":"PMC_24852423","title":"Genetic deletion of Mst1 alters T cell function and protects against autoimmunity.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24852423","citation_count":41,"is_preprint":false},{"pmid":"33879857","id":"PMC_33879857","title":"CCL2 regulation of MST1-mTOR-STAT1 signaling axis controls BCR signaling and B-cell differentiation.","date":"2021","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/33879857","citation_count":41,"is_preprint":false},{"pmid":"32320827","id":"PMC_32320827","title":"Mst1 knockdown alleviates cardiac lipotoxicity and inhibits the development of diabetic cardiomyopathy in db/db mice.","date":"2020","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/32320827","citation_count":41,"is_preprint":false},{"pmid":"32929029","id":"PMC_32929029","title":"Netrin1 deficiency activates MST1 via UNC5B receptor, promoting dopaminergic apoptosis in Parkinson's disease.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32929029","citation_count":39,"is_preprint":false},{"pmid":"24732633","id":"PMC_24732633","title":"Gemcitabine-induced pancreatic cancer cell death is associated with MST1/cyclophilin D mitochondrial complexation.","date":"2014","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/24732633","citation_count":39,"is_preprint":false},{"pmid":"36164986","id":"PMC_36164986","title":"MST1 Suppresses Disturbed Flow Induced Atherosclerosis.","date":"2022","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/36164986","citation_count":37,"is_preprint":false},{"pmid":"31117242","id":"PMC_31117242","title":"MST1 Regulates Neuronal Cell Death via JNK/Casp3 Signaling Pathway in HFD Mouse Brain and HT22 Cells.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31117242","citation_count":37,"is_preprint":false},{"pmid":"31215035","id":"PMC_31215035","title":"Mst1 deletion reduces septic cardiomyopathy via activating Parkin-related mitophagy.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31215035","citation_count":34,"is_preprint":false},{"pmid":"24499724","id":"PMC_24499724","title":"Overexpression of MYC and EZH2 cooperates to epigenetically silence MST1 expression.","date":"2014","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/24499724","citation_count":34,"is_preprint":false},{"pmid":"21249150","id":"PMC_21249150","title":"Cross-regulation between oncogenic BRAF(V600E) kinase and the MST1 pathway in papillary thyroid carcinoma.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21249150","citation_count":34,"is_preprint":false},{"pmid":"27465533","id":"PMC_27465533","title":"Mst1 Kinase Regulates the Actin-Bundling Protein L-Plastin To Promote T Cell Migration.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/27465533","citation_count":31,"is_preprint":false},{"pmid":"32627655","id":"PMC_32627655","title":"LncRNA SNHG17 knockdown promotes Parkin-dependent mitophagy and reduces apoptosis of podocytes through Mst1.","date":"2020","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/32627655","citation_count":31,"is_preprint":false},{"pmid":"26903296","id":"PMC_26903296","title":"Mst1 regulates hepatic lipid metabolism by inhibiting Sirt1 ubiquitination in mice.","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/26903296","citation_count":30,"is_preprint":false},{"pmid":"24747552","id":"PMC_24747552","title":"Constitutively active NDR1-PIF kinase functions independent of MST1 and hMOB1 signalling.","date":"2014","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/24747552","citation_count":30,"is_preprint":false},{"pmid":"38430683","id":"PMC_38430683","title":"Inhibition of MST1 ameliorates neuronal apoptosis via GSK3β/β-TrCP/NRF2 pathway in spinal cord injury accompanied by diabetes.","date":"2024","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/38430683","citation_count":29,"is_preprint":false},{"pmid":"38288904","id":"PMC_38288904","title":"SIRT7 promotes Hippo/YAP activation and cancer cell proliferation in hepatocellular carcinoma via suppressing MST1.","date":"2024","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/38288904","citation_count":29,"is_preprint":false},{"pmid":"29155025","id":"PMC_29155025","title":"Understanding the role of mammalian sterile 20-like kinase 1 (MST1) in cardiovascular disorders.","date":"2017","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/29155025","citation_count":29,"is_preprint":false},{"pmid":"28802229","id":"PMC_28802229","title":"TGF-β-mediated repression of MST1 by DNMT1 promotes glioma malignancy.","date":"2017","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/28802229","citation_count":29,"is_preprint":false},{"pmid":"35642057","id":"PMC_35642057","title":"Metallothionein 2A (MT2A) controls cell proliferation and liver metastasis by controlling the MST1/LATS2/YAP1 signaling pathway in colorectal cancer.","date":"2022","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/35642057","citation_count":29,"is_preprint":false},{"pmid":"30338935","id":"PMC_30338935","title":"Cardiac-specific Mst1 deficiency inhibits ROS-mediated JNK signalling to alleviate Ang II-induced cardiomyocyte apoptosis.","date":"2018","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30338935","citation_count":28,"is_preprint":false},{"pmid":"29296937","id":"PMC_29296937","title":"Mst1 positively regulates B-cell receptor signaling via CD19 transcriptional levels.","date":"2016","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/29296937","citation_count":26,"is_preprint":false},{"pmid":"34807584","id":"PMC_34807584","title":"Inhibitors of the Hippo Pathway Kinases STK3/MST2 and STK4/MST1 Have Utility for the Treatment of Acute Myeloid Leukemia.","date":"2021","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34807584","citation_count":26,"is_preprint":false},{"pmid":"27238285","id":"PMC_27238285","title":"H-ras Inhibits the Hippo Pathway by Promoting Mst1/Mst2 Heterodimerization.","date":"2016","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/27238285","citation_count":26,"is_preprint":false},{"pmid":"32332916","id":"PMC_32332916","title":"Hippo kinases MST1 and MST2 control the differentiation of the epididymal initial segment via the MEK-ERK pathway.","date":"2020","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/32332916","citation_count":26,"is_preprint":false},{"pmid":"27793648","id":"PMC_27793648","title":"Shikonin regulates C-MYC and GLUT1 expression through the MST1-YAP1-TEAD1 axis.","date":"2016","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/27793648","citation_count":25,"is_preprint":false},{"pmid":"34029571","id":"PMC_34029571","title":"Deubiquitinating enzyme USP46 suppresses the progression of hepatocellular carcinoma by stabilizing MST1.","date":"2021","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/34029571","citation_count":24,"is_preprint":false},{"pmid":"28327630","id":"PMC_28327630","title":"Rassf Proteins as Modulators of Mst1 Kinase Activity.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28327630","citation_count":24,"is_preprint":false},{"pmid":"29474739","id":"PMC_29474739","title":"Mst1/2 Kinases Modulate Glucose Uptake for Osteoblast Differentiation and Bone Formation.","date":"2018","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/29474739","citation_count":24,"is_preprint":false},{"pmid":"36623453","id":"PMC_36623453","title":"Mst1-mediated phosphorylation of Nur77 improves the endometrial receptivity in human and mice.","date":"2023","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/36623453","citation_count":22,"is_preprint":false},{"pmid":"32435241","id":"PMC_32435241","title":"MST1/2 Balance Immune Activation and Tolerance by Orchestrating Adhesion, Transcription, and Organelle Dynamics in Lymphocytes.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32435241","citation_count":22,"is_preprint":false},{"pmid":"31951593","id":"PMC_31951593","title":"SRV2 promotes mitochondrial fission and Mst1-Drp1 signaling in LPS-induced septic cardiomyopathy.","date":"2020","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/31951593","citation_count":22,"is_preprint":false},{"pmid":"30320378","id":"PMC_30320378","title":"Mst1 regulates non-small cell lung cancer A549 cell apoptosis by inducing mitochondrial damage via ROCK1/F‑actin pathways.","date":"2018","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30320378","citation_count":22,"is_preprint":false},{"pmid":"31206688","id":"PMC_31206688","title":"Mst1 deletion reduces hyperglycemia-mediated vascular dysfunction via attenuating mitochondrial fission and modulating the JNK signaling pathway.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31206688","citation_count":22,"is_preprint":false},{"pmid":"22847424","id":"PMC_22847424","title":"Tumor suppressor Hippo/MST1 kinase mediates chemotaxis by regulating spreading and adhesion.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22847424","citation_count":21,"is_preprint":false},{"pmid":"33389879","id":"PMC_33389879","title":"Hippo Kinases MST1/2 Regulate Immune Cell Functions in Cancer, Infection, and Autoimmune Diseases.","date":"2020","source":"Critical reviews in eukaryotic gene expression","url":"https://pubmed.ncbi.nlm.nih.gov/33389879","citation_count":20,"is_preprint":false},{"pmid":"25133611","id":"PMC_25133611","title":"Mst1 directs Myosin IIa partitioning of low and higher affinity integrins during T cell migration.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25133611","citation_count":20,"is_preprint":false},{"pmid":"37727684","id":"PMC_37727684","title":"miR-200a-3p overexpression alleviates diabetic cardiomyopathy injury in mice by regulating autophagy through the FOXO3/Mst1/Sirt3/AMPK axis.","date":"2023","source":"PeerJ","url":"https://pubmed.ncbi.nlm.nih.gov/37727684","citation_count":20,"is_preprint":false},{"pmid":"38369002","id":"PMC_38369002","title":"MST1/2: Important regulators of Hippo pathway in immune system associated diseases.","date":"2024","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/38369002","citation_count":19,"is_preprint":false},{"pmid":"29459865","id":"PMC_29459865","title":"The Role of Mst1 in Lymphocyte Homeostasis and Function.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29459865","citation_count":19,"is_preprint":false},{"pmid":"35123978","id":"PMC_35123978","title":"XMU-MP-1 protects heart from ischemia/reperfusion injury in mice through modulating Mst1/AMPK pathway.","date":"2022","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35123978","citation_count":19,"is_preprint":false},{"pmid":"32975614","id":"PMC_32975614","title":"TRAF6-mediated ubiquitination of MST1/STK4 attenuates the TLR4-NF-κB signaling pathway in macrophages.","date":"2020","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/32975614","citation_count":19,"is_preprint":false},{"pmid":"37909712","id":"PMC_37909712","title":"MST1/2 in inflammation and immunity.","date":"2023","source":"Cell adhesion & migration","url":"https://pubmed.ncbi.nlm.nih.gov/37909712","citation_count":18,"is_preprint":false},{"pmid":"24595170","id":"PMC_24595170","title":"Mst1 and mst2 are essential regulators of trophoblast differentiation and placenta morphogenesis.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24595170","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51788,"output_tokens":13597,"usd":0.179659,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":24922,"output_tokens":7693,"usd":0.158468,"stage2_stop_reason":"end_turn"},"total_usd":0.338127,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"MST1 homodimerizes via its extreme C-terminal 57 amino acids, and contains an inhibitory domain within a central 63-amino acid region whose removal increases kinase activity ~9-fold. Loss of dimerization alone does not affect kinase activity, but a molecule lacking both the dimerization and inhibitory domains is less active than one lacking only the inhibitory domain. MST1 also associates with a high molecular weight complex in cells.\",\n      \"method\": \"C-terminal and internal deletion analysis, co-immunoprecipitation, yeast two-hybrid, in vitro cross-linking, size exclusion chromatography\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (Co-IP, yeast two-hybrid, cross-linking, size exclusion) with deletion mutagenesis in a single focused study\",\n      \"pmids\": [\"8702870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"MST1 is specifically cleaved by caspase-3-like activity (blocked by ZVAD-fmk, DEVD-CHO, and CrmA) during Fas/CD95- or staurosporine-induced apoptosis, removing the C-terminal regulatory domain and activating MST1. Overexpression of wild-type or truncated MST1 induces apoptotic morphology; kinase-dead MST1 does not. Activated MST1 activates MKK6, p38 MAPK, MKK7, and SAPK in co-transfection assays. MST1 can also activate caspases that in turn cleave it, forming a positive feedback loop.\",\n      \"method\": \"Caspase inhibitor experiments, in vivo cleavage assays, overexpression of wild-type and kinase-dead mutants, co-transfection kinase activation assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (inhibitor pharmacology, mutagenesis, overexpression) replicated across stimuli in one focused study\",\n      \"pmids\": [\"9545236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Caspase-mediated cleavage of MST1 releases the C-terminal domain containing two functional nuclear export signals (NESs), causing nuclear translocation of the N-terminal kinase domain. Full-length MST1 is cytoplasmic; truncation of the C-terminal domain, NES point mutation, or leptomycin B treatment causes nuclear localization. Nuclear MST1 is more efficient at inducing chromatin condensation; inhibiting cleavage-site mutation reduces chromatin condensation ability.\",\n      \"method\": \"NES mutation, leptomycin B treatment, subcellular fractionation/localization, staurosporine-induced apoptosis assays, kinase-negative mutant expression\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (mutagenesis of NES, pharmacological export inhibition, cleavage-site mutation) in one focused study\",\n      \"pmids\": [\"11517310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"MST1 promotes apoptosis through JNK activation: dominant-negative JNK inhibits MST1-induced morphological changes and caspase-3 activation. MST1 induces CAD-mediated DNA fragmentation via caspase-dependent pathway and induces chromatin condensation and membrane blebbing through a caspase-independent JNK pathway. p38 MAPK is not required for MST1-induced apoptosis.\",\n      \"method\": \"Dominant-negative JNK co-expression, p38 inhibitor (SB203580), caspase inhibitors, ICAD expression, morphological assays\",\n      \"journal\": \"Genes to cells : devoted to molecular & cellular mechanisms\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis by dominant-negative and pharmacological inhibitors, two orthogonal readouts, single lab\",\n      \"pmids\": [\"11442632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"MST1 activation requires phosphorylation at Thr183 (primary site) and Thr187 in subdomain VIII, catalyzed by intermolecular autophosphorylation enhanced by homodimerization. Active MST1 also autophosphorylates at Thr177 and Thr387. Active MST1 activates JNK, caspase-3, and caspase-9. Kinase activity (not caspase cleavage) is required for apoptotic cell detachment. An S327E phosphomimetic mutant confers caspase resistance.\",\n      \"method\": \"Site-directed mutagenesis of phosphorylation sites, in vitro kinase assays, cell detachment and apoptosis assays with phospho-mimetic and phospho-dead mutants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assays with systematic mutagenesis, multiple phosphorylation sites mapped, multiple orthogonal cellular readouts\",\n      \"pmids\": [\"12223493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Death-associated protein 4 (DAP4) binds MST1 through its carboxyl-terminal segment and co-localizes with MST1 in cells. DAP4 does not alter MST1 kinase activity but augments MST1-induced apoptosis in a dose-dependent manner when co-expressed with sub-maximal MST1. MST1-induced apoptosis is suppressed by dominant-negative p53, and DAP4 binds p53, potentially enabling MST1 colocalization with p53.\",\n      \"method\": \"Co-immunoprecipitation, overexpression co-transfection apoptosis assays, dominant-negative p53, in vitro kinase assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — reciprocal Co-IP and in vitro binding, functional augmentation assay, single lab\",\n      \"pmids\": [\"12384512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"RASSF1/Nore1 polypeptides bind MST1 and MST2 through SARAH domain interactions. Recombinant MST1/2, spontaneous dimers, autoactivate in vitro through intradimer transphosphorylation of the activation loop; Nore1/RASSF1 polypeptides inhibit this autoactivation. Membrane-recruited MST1 is strongly activated in vivo; MST1 bound to RasG12V through Nore1A is activated.\",\n      \"method\": \"In vitro kinase reconstitution, SARAH domain binding assays, membrane recruitment experiments, co-immunoprecipitation of endogenous complexes\",\n      \"journal\": \"Methods in enzymology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution of autoactivation and inhibition by RASSF/Nore1, single lab review/methods paper\",\n      \"pmids\": [\"16757333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"MST1 is a physiological interaction partner of Akt1, identified in lipid raft-enriched fractions from prostate cancer cells. Endogenous MST1 (and MST2) inhibit endogenous Akt1 activity. Both full-length MST1 and its two caspase cleavage products complex with and inhibit Akt1. MST1 cRNAs revert an early lethal phenotype in zebrafish induced by membrane-targeted Akt1.\",\n      \"method\": \"Co-immunoprecipitation from lipid raft fractions, endogenous kinase activity assays, zebrafish rescue experiments\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — endogenous Co-IP, functional rescue in zebrafish, single lab with two orthogonal systems\",\n      \"pmids\": [\"17932490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"MST1 and MST2 are activated during mitosis (especially in nocodazole-arrested cells). MST1/2 phosphorylate MOBKL1A and MOBKL1B (Drosophila MATS homologs) in vitro and in cells in an MST1/2-dependent manner during mitosis and in response to okadaic acid or H2O2. MST1/2-catalyzed MOB phosphorylation promotes MOB binding to LATS1 and enables H2O2-stimulated LATS1 activation loop phosphorylation. Non-phosphorylatable MOB mutant replacement accelerates cell proliferation by speeding G1/S and mitotic exit.\",\n      \"method\": \"In vitro kinase assays, cell-based phosphorylation with MST1/2 knockdown/overexpression, replacement of endogenous MOB with non-phosphorylatable mutant, cell cycle analysis\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro substrate phosphorylation, cell-based MST-dependent phosphorylation, non-phosphorylatable mutant rescue; multiple orthogonal methods in focused study\",\n      \"pmids\": [\"18328708\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The Nore1B/RAPL-MST1 complex restrains antigen receptor-induced proliferation of naive T cells. MST1-null naive T cells show markedly greater TCR-stimulated proliferation; among known MST1 substrates, only MOBKL1A/B phosphorylation is entirely lost in TCR-stimulated, MST1-deficient T cells. MST1-null T cells exhibit defective LFA-1 clustering. Mst1-null mice have reduced Nore1B/RAPL in lymphoid cells.\",\n      \"method\": \"MST1 knockout mice, in vitro proliferation assays, substrate phosphorylation analysis, LFA-1 clustering microscopy\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined cellular and molecular phenotype, substrate phosphorylation loss confirmed, replicated across multiple readouts\",\n      \"pmids\": [\"19073936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MST1 phosphorylates FOXO1 at Ser212 (corresponding to Ser207 in FOXO3), disrupting FOXO1 association with 14-3-3 proteins and promoting FOXO1 nuclear translocation in cerebellar granule neurons deprived of neuronal activity. MST1 is required for neuronal death upon growth factor/activity withdrawal, and MST1 promotes cell death in a FOXO1-dependent manner. The scaffold protein Nore1 is also required for survival factor deprivation-induced neuronal death.\",\n      \"method\": \"Phosphorylation assays, 14-3-3 co-immunoprecipitation, nuclear translocation imaging, MST1 loss-of-function in primary neurons, FOXO1-dependent rescue experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — kinase assay identifying phosphorylation site, 14-3-3 dissociation, nuclear translocation, and FOXO1-dependent cell death, multiple orthogonal methods\",\n      \"pmids\": [\"19221179\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Mst1 and Mst2 are cleaved and constitutively activated in mouse liver. Combined Mst1/2 deficiency leads to loss of inhibitory Ser127 phosphorylation of YAP1, liver overgrowth, and hepatocellular carcinoma. Re-expression of Mst1 in HCC cell lines promotes YAP1 Ser127 phosphorylation/inactivation and abolishes tumorigenicity. Mst1/2 inactivates YAP1 in liver through an intermediary kinase distinct from Lats1/2.\",\n      \"method\": \"Conditional liver-specific Mst1/2 knockout mice, YAP1 phosphorylation western blot, HCC cell line re-expression with tumorigenicity assays, epistasis analysis\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean conditional KO with defined pathway epistasis and rescue by re-expression, replicated across mouse model and cell lines\",\n      \"pmids\": [\"19878874\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Mst1 is required for lymphocyte trafficking in vivo. Mst1-/- lymphocytes show impaired firm adhesion to high endothelial venules and reduced stopping time on endothelium under physiological shear, defective stabilization of α4 integrin-mediated adhesion, and impaired motility within lymph nodes. L-selectin-dependent rolling/tethering was not affected.\",\n      \"method\": \"Mst1 knockout mice, in vitro adhesion cascade assays under shear flow, intravital imaging within lymph nodes\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined adhesion/migration phenotype, multiple in vitro and in vivo assays, single lab\",\n      \"pmids\": [\"19339990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Mst1 and Mst2 act redundantly to control organ size and suppress tumorigenesis; combined deletion (Mst1-/-; Mst2-/-) causes early embryonic lethality and is required to control YAP phosphorylation and activity in vivo. TNFα-induced apoptosis is blocked in Mst1/Mst2 double-mutant cells both in vivo and in vitro.\",\n      \"method\": \"Mst1/Mst2 double-knockout mice, YAP phosphorylation assays, TNFα-induced apoptosis assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic double KO with multiple defined phenotypes, YAP phosphorylation molecular readout confirmed in vivo\",\n      \"pmids\": [\"20080598\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"MST1 promotes accurate kinetochore-microtubule attachment by phosphorylating Aurora B directly (in vitro), inhibiting its kinase activity. MST1 depletion increases Aurora B activity and causes unaligned mitotic chromosomes with Mad2/BubR1-dependent spindle checkpoint activation. MST1 and NDR1 (downstream kinase of MST1) associate with Aurora B; NDR1 depletion phenocopies MST1 depletion; Aurora B depletion rescues kinetochore-microtubule attachment defects in MST1/NDR1-depleted cells.\",\n      \"method\": \"MST1/NDR1 RNAi, in vitro kinase assay (MST1 phosphorylation of Aurora B), co-immunoprecipitation, live-cell microscopy, spindle checkpoint assay\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay showing direct phosphorylation, Co-IP, epistasis by Aurora B depletion rescue, single lab\",\n      \"pmids\": [\"20171103\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PHLPP phosphatases bind MST1 both in vivo and in vitro, dephosphorylate MST1 at inhibitory Thr387, activating MST1 and its downstream effectors p38 and JNK to induce apoptosis. Akt phosphorylates Thr387 to inhibit MST1. PHLPP, Akt, and MST1 form an autoinhibitory triangle controlling apoptosis/proliferation balance.\",\n      \"method\": \"Co-immunoprecipitation, in vitro phosphatase and kinase assays, mutant MST1 T387 analysis, p38/JNK activation assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro phosphatase assay, Co-IP, kinase assays with mutagenesis, multiple orthogonal methods in single study\",\n      \"pmids\": [\"20513427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"c-Abl tyrosine kinase phosphorylates MST1 at Tyr433, triggering MST1 stabilization and activation. Inhibition of c-Abl promotes MST1 degradation via CHIP-mediated ubiquitination. Oxidative stress induces c-Abl-dependent tyrosine phosphorylation of MST1 and increases the MST1-FOXO3 interaction, activating the MST1-FOXO signaling pathway leading to neuronal cell death.\",\n      \"method\": \"In vitro kinase assay (c-Abl phosphorylation of MST1), c-Abl inhibitor/RNAi, CHIP ubiquitination assays, co-immunoprecipitation (MST1-FOXO3), primary neuron and hippocampal neuron assays\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro kinase assay with site identification, ubiquitination assay, Co-IP, multiple orthogonal methods in single lab\",\n      \"pmids\": [\"21715626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"MST1 promotes apoptosis in a p53-dependent manner by phosphorylating Sirt1, inhibiting its deacetylase activity and its interaction with p53, thereby increasing p53 acetylation and transactivation. This defines an MST1-Sirt1-p53 signaling axis in DNA damage-induced apoptosis.\",\n      \"method\": \"In vitro kinase assay (MST1 phosphorylation of Sirt1), co-immunoprecipitation (Sirt1-p53), Sirt1 activity assay, p53 acetylation/transactivation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro kinase assay, Sirt1 activity assay, Co-IP; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"21212262\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Mst1 and Mst2 control thymic egress and T cell migration by activating Rho GTPases Rac1 and RhoA. MST1/2-deficient SP thymocytes show abolished sphingosine-1-phosphate- and CCL21-induced Mob1 phosphorylation, Rac1/RhoA GTP charging, and cell migration. When phosphorylated by Mst1/Mst2, Mob1 binds and activates the Rac1 guanyl nucleotide exchanger Dock8.\",\n      \"method\": \"Mst1/2 double-knockout hematopoietic cells, Mob1 phosphorylation assays, Rac1/RhoA GTP charging assays, Dock8 co-immunoprecipitation with phospho-Mob1, migration assays\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — clean double KO with defined molecular (GTP charging, Mob1 phosphorylation, Dock8 binding) and cellular (migration) phenotypes, multiple methods\",\n      \"pmids\": [\"22412158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"MST1 is activated under diabetogenic conditions in beta cells and directly phosphorylates the beta cell transcription factor PDX1 at Thr11, causing PDX1 ubiquitination and proteasomal degradation, leading to impaired insulin secretion. MST1 also induces mitochondria-dependent apoptosis through upregulation of BIM (BH3-only protein). MST1 deficiency restores normoglycemia and beta cell function in vivo.\",\n      \"method\": \"In vitro kinase assay (MST1 phosphorylation of PDX1 at T11), ubiquitination assay, MST1 knockout/transgenic mouse models, islet apoptosis assays\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay identifying phosphorylation site, ubiquitination assay, KO/transgenic mouse models with functional rescue; multiple orthogonal methods\",\n      \"pmids\": [\"24633305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Mst1 promotes cardiac myocyte apoptosis through a K-Ras/RASSF1A/Mst1 complex localized to mitochondria in response to oxidative stress. Activated Mst1 phosphorylates Bcl-xL at Ser14 (within the BH4 domain), antagonizing Bcl-xL-Bax binding and causing Bax activation and mitochondria-mediated apoptosis.\",\n      \"method\": \"In vitro kinase assay (Mst1 phosphorylation of Bcl-xL at Ser14), co-immunoprecipitation of K-Ras/RASSF1A/Mst1 complex, mitochondrial fractionation, Bax activation assay, cardiac myocyte apoptosis assay\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with site identification, mitochondrial localization of complex, Bax activation, multiple orthogonal methods in single study\",\n      \"pmids\": [\"24813943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The MST1/2-SAV1 complex promotes ciliogenesis. MST1 localizes to the basal body of cilia and is activated during ciliogenesis. MST1/2 binds and phosphorylates Aurora kinase A (AURKA), leading to dissociation of the AURKA/HDAC6 cilia-disassembly complex. MST1/2-SAV1 also associates with the NPHP transition-zone complex, promoting ciliary localization of ciliary cargoes.\",\n      \"method\": \"MST1/2 or SAV1 depletion in cultured cells and zebrafish, immunolocalization to basal body, in vitro kinase assay (MST1 phosphorylation of AURKA), co-immunoprecipitation with AURKA/HDAC6 and NPHP complex\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vitro kinase assay, multiple Co-IP, localization, depletion phenotype in cells and zebrafish; multiple orthogonal methods\",\n      \"pmids\": [\"25367221\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Mst1 and Mst2 positively regulate phagocytic ROS production by controlling mitochondrial trafficking to phagosomes. Mst1/2 activate the GTPase Rac to promote TLR-triggered assembly of the TRAF6-ECSIT complex required for mitochondrial recruitment to phagosomes. Inactive Rac2(D57N) disrupts the TRAF6-ECSIT complex by sequestering TRAF6.\",\n      \"method\": \"Mst1/2 knockout macrophages, Rac activation assays, TRAF6-ECSIT co-immunoprecipitation, mitochondrion-phagosome colocalization imaging, ROS measurement, bactericidal assays\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined molecular (Rac activation, TRAF6-ECSIT complex) and functional (ROS, bactericidal) phenotypes, multiple orthogonal methods\",\n      \"pmids\": [\"26414765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"mTORC2 (Rictor complex) directly phosphorylates MST1 at Ser438 in the SARAH domain, thereby reducing MST1 homodimerization and kinase activity. Cardiac-specific mTORC2 disruption (Rictor deletion) causes marked activation of MST1, leading to cardiac dysfunction and dilation under pressure overload.\",\n      \"method\": \"In vitro kinase assay (mTORC2 phosphorylation of MST1 at S438), site-directed mutagenesis, cardiac-specific Rictor KO mice, MST1 dimerization and activity assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay identifying phosphorylation site, mutagenesis, clean cardiac KO with defined phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"25843706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Mst1 shuts off cytosolic antiviral defense by directly associating with IRF3 and phosphorylating it at Thr75 and Thr253, abolishing activated IRF3 homodimerization, chromatin occupancy, and IRF3-mediated transcription. Mst1 also impedes virus-induced TBK1 activation, further attenuating IRF3 activation. Mst1 depletion or ablation enhances antiviral response. Mst2 does not have this effect.\",\n      \"method\": \"Functional kinome screen, in vitro kinase assay (MST1 phosphorylation of IRF3 at T75/T253), co-immunoprecipitation (MST1-IRF3), IRF3 homodimerization assay, chromatin occupancy assay, MST1 KO mice with viral challenge\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vitro kinase assay with site mapping, multiple cell-based assays, KO mice with defined antiviral phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"27125670\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"DLG5 functions as an evolutionarily conserved scaffold that links MST1/2 with Par-1 polarity proteins (MARK1/2/3), inhibiting MST1/2 kinase activity and the MST1/2-LATS1/2 association. Hippo signaling is hyperactive in Dlg5-/- tissues; conditional deletion of Mst1/2 fully rescues the phenotypes of brain-specific Dlg5-KO mice.\",\n      \"method\": \"Affinity purification/mass spectrometry, MST1/2 kinase activity assay in DLG5-null cells, genetic rescue (Mst1/2 conditional deletion in Dlg5-KO), co-immunoprecipitation\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — AP-MS identification, kinase activity assay, genetic epistasis rescue, multiple orthogonal methods\",\n      \"pmids\": [\"28087714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"H-ras promotes formation of inactive Mst1/Mst2 heterodimers via an Erk-dependent mechanism. Mst1/Mst2 heterodimerize in cells through SARAH domains, and these heterodimers have much-reduced kinase activity compared to Mst1 or Mst2 homodimers. Cells lacking Mst1 are resistant to H-ras-mediated transformation and maintain active Hippo pathway signaling.\",\n      \"method\": \"Co-immunoprecipitation of Mst1/Mst2 heterodimers, SARAH domain deletion/mutation, kinase activity assay of hetero- vs. homodimers, H-ras transformation assays, Mst1-KO cells\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — Co-IP, in vitro kinase comparison, SARAH domain mutagenesis, transformation assay, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"27238285\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Pharmacological inhibition of MST1/2 with XMU-MP-1 (a selective, reversible inhibitor) blocks MST1/2 kinase activities, thereby activating downstream YAP and promoting cell growth. Co-crystal structure confirmed XMU-MP-1 binds on-target to MST1/2. XMU-MP-1 augments intestinal and liver repair/regeneration in mouse models.\",\n      \"method\": \"ELISA-based high-throughput biochemical kinase assay, co-crystal structure of XMU-MP-1 with MST1/2, structure-activity relationship, in vivo pharmacokinetics, mouse injury models\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — co-crystal structure confirming on-target binding, in vitro kinase assay, in vivo pharmacodynamics, multiple orthogonal methods\",\n      \"pmids\": [\"27535619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Mst1 kinase phosphorylates the actin-bundling protein L-plastin (LPL) at Thr89 in vitro, and Mst1 interacts with LPL in cells. Mutation of Thr89 to Ala impairs LPL localization to lamellipodia and fails to restore T cell migration in LPL-deficient cells or rescue thymic egress in bone marrow chimeras.\",\n      \"method\": \"In vitro kinase assay (MST1 phosphorylation of LPL at T89), co-immunoprecipitation, T89A mutant expression, T cell migration assays, bone marrow chimeras\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro kinase assay with site identification, T89A non-phosphorylatable mutant functional analysis, Co-IP; multiple orthogonal methods\",\n      \"pmids\": [\"27465533\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Rassf1A and Rassf5 modulate MST1 activity via SARAH domain heterodimerization; the MST1 N-terminal kinase domain also plays a role in stabilizing the complex beyond SARAH-SARAH interaction. Rassf-MST1 complex positively regulates MST1-H2B Ser14 phosphorylation (chromatin condensation marker) while suppressing MST1-FoxO phosphorylation.\",\n      \"method\": \"Surface plasmon resonance (domain mapping), in vitro kinase assays (H2B and FoxO phosphorylation by MST1 in presence/absence of Rassf), domain deletion/mutagenesis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — SPR binding assays and in vitro kinase assays with multiple substrates; single lab\",\n      \"pmids\": [\"28327630\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MST1 is a component of the TNFα receptor 1 signaling complex (TNF-RSC). TNFα induces MST1 recruitment to TNF-RSC and interaction with HOIP (catalytic LUBAC component). Activated MST1 phosphorylates HOIP, inhibiting LUBAC-dependent linear ubiquitination of NEMO/IKKγ, thereby attenuating TNFα-induced NF-κB signaling. MST1 genetic ablation potentiates IKK activity and NF-κB target gene expression.\",\n      \"method\": \"Co-immunoprecipitation of MST1 with TNF-RSC, in vitro kinase assay (MST1 phosphorylation of HOIP), LUBAC ubiquitination assay, MST1 KO MEFs and macrophages, NF-κB reporter and cytokine assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vitro kinase assay, ubiquitination assay, Co-IP, clean KO with NF-κB pathway readout; multiple orthogonal methods\",\n      \"pmids\": [\"30901564\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MST1/2 act as signal-dependent amplifiers of IL-2-STAT5 activity in regulatory T cells. Unbiased quantitative proteomics revealed MST1 association with the cytoskeletal DOCK8-LRCHs module. MST1 deficiency limits Treg cell migration, access to IL-2, and activity of the small GTPase Rac, which mediates downstream STAT5 activation.\",\n      \"method\": \"Conditional Mst1/Mst2 KO in Treg cells, quantitative proteomics (AP-MS), Rac GTPase activity assay, STAT5 phosphorylation assay, Treg migration assays, IL-2 signaling assays\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with defined molecular (Rac, STAT5) and cellular (migration, suppression) phenotypes, proteomics-identified DOCK8-LRCHs interaction, multiple orthogonal methods\",\n      \"pmids\": [\"30413360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MST1 directly phosphorylates and binds the netrin receptor UNC5B at Thr428, promoting its apoptotic activation and dopaminergic neuronal loss in the context of Netrin1 reduction. MST1 activation by Netrin1 deprivation diminishes YAP levels and increases cell death. Knockout of UNC5B abolishes netrin depletion-induced dopaminergic loss; blockade of MST1-UNC5B phosphorylation suppresses neuronal apoptosis.\",\n      \"method\": \"In vitro kinase assay (MST1 phosphorylation of UNC5B at T428), co-immunoprecipitation (MST1-UNC5B), UNC5B knockout, phospho-specific antibody, dopaminergic neuron apoptosis assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro kinase assay with site identification, phospho-specific detection, KO rescue, Co-IP; multiple orthogonal methods in single study\",\n      \"pmids\": [\"32929029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MST1 directly phosphorylates Nur77 (nuclear receptor) at Thr366, promoting Nur77 transcriptional activity and upregulating downstream β3-integrin expression to improve endometrial receptivity. Endometrial phospho-Nur77 (T366) level is decreased in women with recurrent implantation failure.\",\n      \"method\": \"In vitro kinase assay followed by LC-MS/MS (identification of T366 phosphorylation site), phos-tag SDS-PAGE, phospho-specific antibody, luciferase transcriptional assay, embryo adhesion assay, delayed implantation mouse model\",\n      \"journal\": \"EBioMedicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with MS-based site identification, multiple functional readouts (transcription, embryo adhesion, in vivo implantation), single lab\",\n      \"pmids\": [\"36623453\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Gemcitabine activates MST1 through ROS production in pancreatic cancer cells; activated MST1 translocates to mitochondria and forms a complex with cyclophilin D (Cyp-D). MST1/Cyp-D mitochondrial complexation is required for gemcitabine-induced cell death; cyclosporin A (Cyp-D inhibitor) prevents this complexation and cell death.\",\n      \"method\": \"Co-immunoprecipitation (MST1-CypD), mitochondrial fractionation, ROS assay, shRNA silencing of MST1/CypD, cyclosporin A treatment, cell death assays\",\n      \"journal\": \"Biochimie\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP, fractionation, pharmacological inhibition, and RNAi; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"24732633\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Akt phosphorylates MST1 at Thr120, inhibiting MST1 kinase activity, nuclear translocation, and autophosphorylation at Thr183. Phospho-T120 MST1 fails to activate downstream FOXO3a and JNK. An inverse correlation between pMST1-T120 and pMST1-T183 is observed in human ovarian tumors.\",\n      \"method\": \"In vitro kinase assay (Akt phosphorylation of MST1 at T120), T120 mutant analysis, Akt-MST1 co-immunoprecipitation, nuclear translocation assay, FOXO3a/JNK activation assays, human tumor analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro kinase assay with site identification, Co-IP, mutagenesis, multiple downstream readouts in single focused study\",\n      \"pmids\": [\"19940129\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TRAF6 mediates LPS-induced ubiquitination of MST1/STK4 in macrophages, resulting in negative feedback regulation. MST1 inhibits TRAF6 autoubiquitination and TRAF6-mediated downstream NF-κB signaling. Myeloid-specific MST1 ablation enhances NF-κB activation and proinflammatory cytokine production after LPS, and increases susceptibility to LPS-induced septic shock.\",\n      \"method\": \"Myeloid-specific MST1 KO mice, ubiquitination assays, TRAF6 autoubiquitination assay, co-immunoprecipitation, NF-κB reporter, cytokine measurement, septic shock model\",\n      \"journal\": \"Cellular and molecular life sciences : CMLS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean myeloid KO with defined molecular and in vivo phenotypes, ubiquitination and signaling assays; multiple orthogonal methods\",\n      \"pmids\": [\"32975614\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MST1 directly phosphorylates p53, promoting neuronal apoptosis and Alzheimer's disease-like cognitive deficits. MST1 associates with p53; p53 knockout largely reverses MST1-induced AD-like cognitive deficits.\",\n      \"method\": \"Co-immunoprecipitation (MST1-p53), MST1 overexpression in normal and 5xFAD mice, p53 knockout rescue, cognitive and synaptic plasticity assays\",\n      \"journal\": \"Progress in neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP, genetic epistasis (p53 KO rescue), MST1 overexpression phenotype; single lab, phosphorylation site not formally mapped in abstract\",\n      \"pmids\": [\"35525373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MST1 phosphorylates Cx43 (connexin 43) at Ser255 in endothelial cells; this phosphorylation closes Cx43 hemichannels and prevents EC activation. Oscillatory shear stress inhibits MST1 phosphorylation, leading to reduced pCx43-S255, Cx43 hemichannel opening (mediated by Filamin B-dependent translocation of Cx43 to lipid rafts), EC activation, and atherosclerosis.\",\n      \"method\": \"Mass spectrometry (substrate identification), Co-IP, proximity ligation assay, dye uptake assay (hemichannel function), lentiviral MST1/Cx43-S255 overexpression, EC-specific Mst1-KO/ApoE mice in carotid ligation atherosclerosis model\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — MS substrate identification, hemichannel functional assay, phosphomimetic rescue in vivo, multiple orthogonal methods in single focused study\",\n      \"pmids\": [\"36164986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MST1 suppresses pancreatic cancer via ROS-induced caspase-1-dependent pyroptosis. This mechanism is independent of the Hippo/YAP pathway; ROS scavenger N-acetylcysteine attenuates MST1-induced caspase-1 activation and cell death.\",\n      \"method\": \"MST1 overexpression in PDAC cells, caspase-1 activity assay, ROS measurement, N-acetylcysteine rescue, cell death/proliferation/migration/invasion assays, YAP pathway epistasis\",\n      \"journal\": \"Molecular cancer research : MCR\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — functional assays with pharmacological rescue and pathway epistasis, single lab, mechanism not fully reconstituted in vitro\",\n      \"pmids\": [\"30796177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"MST1 negatively regulates Hippo signaling in dendritic cells through the p38 MAPK pathway: MST1 deficiency in DCs increases p38 MAPK activation, leading to increased IL-6 secretion and subsequent STAT3 activation in CD4+ T cells, promoting Th17 differentiation.\",\n      \"method\": \"DC-specific MST1 KO/overexpression, p38 MAPK activation assay, IL-6 ELISA, STAT3 activation assay, Th17 differentiation assay, EAE model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — DC-specific KO with defined molecular pathway (p38-IL6-STAT3) and in vivo phenotype; single lab\",\n      \"pmids\": [\"28145433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"FGFR4 phosphorylates MST1 at Tyr433 in a kinase activity-dependent manner (confirmed by mass spectrometry). Y433F mutation in MST1 induces MST1 activation (increased Thr phosphorylation of MST1/2 and MOB1). FGFR4 inhibition leads to increased MST1/2 activation, enhanced MST1 nuclear localization, and generation of cleaved/autophosphorylated MST1, and apoptosis.\",\n      \"method\": \"Kinase substrate screen, mass spectrometry (Y433 phosphorylation), Y433F mutagenesis, MST1/2/MOB1 phosphorylation assays, FGFR4 knockdown/inhibition, nuclear localization imaging\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — MS-confirmed phosphorylation site, mutagenesis, kinase activity readouts, multiple orthogonal methods in single study\",\n      \"pmids\": [\"30903103\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SIRT7 suppresses MST1 through dual mechanisms: (1) transcriptional repression by binding the MST1 promoter and inducing H3K18 deacetylation, and (2) direct binding and deacetylation of MST1 protein, priming acetylation-dependent MST1 ubiquitination and proteasomal degradation. MST1 reduction promotes YAP nuclear localization and transcriptional activation in liver cancer.\",\n      \"method\": \"ChIP (SIRT7 on MST1 promoter, H3K18ac), co-immunoprecipitation (SIRT7-MST1), mass spectrometry (MST1 deacetylation sites), ubiquitination assay, luciferase (MST1 promoter activity), YAP nuclear localization assay, xenograft mouse model\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP, MS-confirmed deacetylation, ubiquitination assay, Co-IP, multiple orthogonal methods in single focused study\",\n      \"pmids\": [\"38288904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"USP46 directly binds MST1 and decreases its ubiquitination (stabilizes MST1 protein), thereby potentiating MST1 kinase activity to suppress YAP1 and HCC progression.\",\n      \"method\": \"Co-immunoprecipitation (USP46-MST1), ubiquitination assay, MST1 protein stability assay, YAP1 activity assay, HCC cell proliferation/invasion, in vivo xenograft\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP, ubiquitination assay, functional rescue; single lab\",\n      \"pmids\": [\"34029571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"MST1 promotes Sirt1 stability by inhibiting Sirt1 ubiquitination in hepatocytes. Mst1-/- mice show impaired fasting-induced hepatic Sirt1 expression. MST1 overexpression inhibits Srebp-1c expression and increases antioxidant gene expression in primary hepatocytes.\",\n      \"method\": \"Mst1 knockout mice (fasting/HFD model), ubiquitination assay for Sirt1, Sirt1 and Srebp-1c western blot in primary hepatocytes with MST1 overexpression\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Sirt1 ubiquitination assay, KO mice with molecular readout; single lab, mechanistic link not fully reconstituted\",\n      \"pmids\": [\"26903296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Mst1 regulates MST1-mediated endothelial tip cell polarity and sprouting angiogenesis via a ROS-MST1-FOXO1 cascade. Hypoxia activates MST1 through mitochondrial ROS; activated MST1 promotes FOXO1 nuclear import, augmenting transcription of polarity and migration-associated genes.\",\n      \"method\": \"Endothelial-specific MST1 or FOXO1 deletion mice, ROS measurement, MST1 kinase activation assay, FOXO1 nuclear translocation imaging, sprouting angiogenesis (retinal and OIR models)\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — endothelial-specific KO of MST1 and FOXO1, defined molecular (ROS, FOXO1 nuclear import) and in vivo vascular phenotypes, multiple orthogonal methods\",\n      \"pmids\": [\"30783090\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MST1 (STK4) is a Ste20-family serine/threonine kinase that homodimerizes via a C-terminal SARAH domain (activating intermolecular autophosphorylation at Thr183/Thr187) and is held inactive by a central inhibitory domain; it is activated by caspase-3 cleavage (releasing the kinase domain to the nucleus where it phosphorylates histone H2B and promotes chromatin condensation), by intermolecular transphosphorylation, and by upstream kinases c-Abl (pY433) while being negatively regulated by Akt (pT120), mTORC2 (pS438), and FGFR4 (pY433); its major physiological substrates include MOB1/MOBKL1 (activating LATS1/2 to phosphorylate and inactivate YAP1), FOXO1/3 (promoting nuclear entry and apoptotic transcription), Bcl-xL (pS14, antagonizing Bax binding), PDX1 (pT11, triggering proteasomal degradation), IRF3 (pT75/T253, suppressing antiviral signaling), Aurora B (inhibiting kinetochore-microtubule destabilization), HOIP/LUBAC (attenuating NF-κB), AURKA (promoting ciliogenesis), L-plastin (pT89, directing T cell migration), Cx43 (pS255, closing hemichannels), Nur77 (pT366, promoting endometrial receptivity), and UNC5B (pT428, promoting apoptosis); it interacts with scaffold proteins RASSF1/Nore1 (via SARAH domains), SAV1, and DOCK8, and can be stabilized or degraded via ubiquitination controlled by USP46 and SIRT7/TRAF6, respectively, placing MST1 as a central integrator of the Hippo tumor-suppressor cascade, apoptosis, immune cell trafficking, mitochondrial homeostasis, and antiviral defense.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MST1 (STK4) is a Ste20-family serine/threonine kinase that serves as a central integrator of growth-suppressive, apoptotic, and immune-regulatory signaling, most prominently as the apical kinase of the Hippo tumor-suppressor cascade [#11, #13]. The kinase homodimerizes through its extreme C-terminal SARAH domain and is held in check by a central inhibitory region; full activation requires intermolecular autophosphorylation of the activation loop at Thr183/Thr187, which is potentiated by dimerization [#0, #4]. A second, irreversible activation route is caspase-3 cleavage, which excises the C-terminal regulatory domain bearing nuclear export signals, freeing the kinase domain to enter the nucleus, phosphorylate histones, and drive chromatin condensation and apoptosis [#1, #2]. In the Hippo pathway, MST1 phosphorylates MOB1/MOBKL1, which licenses LATS-mediated inactivating phosphorylation of YAP, restraining proliferation and tumorigenesis in liver and other tissues [#8, #11]. Beyond Hippo, MST1 phosphorylates a broad substrate set to enforce apoptosis and cellular homeostasis, including FOXO1/3 (disrupting 14-3-3 binding to drive nuclear import and death) [#10], Bcl-xL at a mitochondrial complex [#20], PDX1 (triggering its degradation in beta cells) [#19], Aurora B (ensuring accurate kinetochore-microtubule attachment) [#14], AURKA (promoting ciliogenesis) [#21], and the antiviral factor IRF3 and the LUBAC component HOIP (both attenuating innate-immune transcriptional output) [#24, #30]. In lymphocytes and myeloid cells MST1 governs adhesion, trafficking, and effector function largely through MOB1-DOCK8-Rac/RhoA signaling and cytoskeletal substrates such as L-plastin [#9, #12, #18, #28, #31]. MST1 activity is tuned by an extensive regulatory network: it is inhibited by Akt (Thr120), mTORC2 (Ser438), and FGFR4 (Tyr433), activated by c-Abl (Tyr433) and the phosphatase PHLPP (removing inhibitory Thr387), and its protein level is set by opposing ubiquitin machineries stabilized by USP46 and degraded via SIRT7/TRAF6 [#15, #16, #23, #35, #41, #42, #43]. Scaffold proteins of the RASSF/Nore1 family and SAV1 bind MST1 via SARAH domains and bias its substrate selectivity [#6, #29].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established the autoregulatory architecture of MST1 — how a constitutively folded kinase keeps itself off — by mapping a C-terminal dimerization module and a separable central inhibitory domain.\",\n      \"evidence\": \"Deletion mutagenesis with Co-IP, yeast two-hybrid, cross-linking, and size exclusion chromatography\",\n      \"pmids\": [\"8702870\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the physiological trigger that relieves inhibition\", \"No structure of the autoinhibited dimer\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined caspase-3 cleavage as an apoptotic activation switch, showing MST1 is both an effector and amplifier of cell death through a caspase feedback loop and stress-kinase activation.\",\n      \"evidence\": \"Caspase inhibitor pharmacology, in vivo cleavage assays, and kinase-dead/truncation overexpression during Fas and staurosporine apoptosis\",\n      \"pmids\": [\"9545236\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve whether cleavage is required versus sufficient for physiological apoptosis\", \"Downstream substrates of nuclear MST1 not yet identified\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Explained how cleavage couples to function spatially: removal of the C-terminal NES-bearing fragment relocalizes the kinase to the nucleus, linking cleavage to chromatin condensation.\",\n      \"evidence\": \"NES mutagenesis, leptomycin B export inhibition, and subcellular fractionation in apoptotic cells (PNAS); JNK-dependence and CAD-mediated DNA fragmentation epistasis (Genes Cells)\",\n      \"pmids\": [\"11517310\", \"11442632\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Nuclear substrates driving condensation not defined\", \"Relative contribution of caspase-dependent versus JNK arms left unquantified\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Mapped the activating phosphorylation code (Thr183/Thr187 by dimerization-enhanced intermolecular autophosphorylation) and identified the first direct binding partner augmenting apoptosis.\",\n      \"evidence\": \"Site-directed mutagenesis with in vitro kinase and detachment/apoptosis assays (JBC); DAP4 Co-IP and p53-dependence (JBC)\",\n      \"pmids\": [\"12223493\", \"12384512\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream kinase versus pure autophosphorylation contributions unresolved\", \"DAP4 link to p53 functional consequence inferred, not reconstituted\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Reconstituted spontaneous dimer autoactivation in vitro and showed RASSF/Nore1 scaffolds act through the SARAH domain to control activation, establishing membrane recruitment as an activating context.\",\n      \"evidence\": \"In vitro kinase reconstitution, SARAH binding assays, and membrane/Ras recruitment experiments\",\n      \"pmids\": [\"16757333\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Methods-paper format limits independent functional follow-up\", \"Direction of RASSF effect (inhibit vs. recruit-activate) context-dependent and unresolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Positioned MST1 in reciprocal antagonism with Akt, identifying it as a lipid-raft Akt1 interactor and inhibitor relevant to survival signaling.\",\n      \"evidence\": \"Co-IP from lipid raft fractions, endogenous kinase activity assays, and zebrafish rescue of membrane-Akt1 lethality\",\n      \"pmids\": [\"17932490\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of Akt inhibition (catalytic vs. sequestration) not defined\", \"Reciprocal Akt-on-MST1 regulation addressed only later\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified MOB1/MOBKL1 as the direct substrate connecting MST1 to LATS activation, anchoring MST1 as an apical Hippo kinase controlling cell-cycle progression.\",\n      \"evidence\": \"In vitro kinase assays, MST-dependent cellular phosphorylation, and non-phosphorylatable MOB knock-in with cell-cycle analysis\",\n      \"pmids\": [\"18328708\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish in vivo organ-size relevance (addressed in genetic models)\", \"Mitotic activation trigger upstream of MST1 unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Genetic loss-of-function across multiple systems revealed MST1's physiological roles: T-cell proliferation/adhesion control, neuronal FOXO1-dependent death, and bona fide liver tumor suppression via YAP inactivation.\",\n      \"evidence\": \"MST1-knockout T cells with substrate phosphorylation and adhesion assays (PNAS, EMBO J); FOXO1 Ser212 phosphorylation and 14-3-3 dissociation in neurons (JBC); conditional liver Mst1/2 KO with YAP Ser127 and HCC rescue (Cancer Cell); Akt phosphorylation of MST1 Thr120 (JBC)\",\n      \"pmids\": [\"19073936\", \"19339990\", \"19221179\", \"19878874\", \"19940129\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Liver YAP regulation attributed to a LATS-distinct intermediary kinase not identified\", \"Tissue-specific substrate selection mechanisms unresolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Solidified MST1/2 redundancy in organ-size/tumor control and expanded the substrate repertoire to mitotic fidelity (Aurora B) and apoptotic transcription (Sirt1-p53), while defining the PHLPP/Akt/Thr387 activity rheostat.\",\n      \"evidence\": \"Mst1/2 double-KO mice with YAP and TNFα-apoptosis readouts (PNAS); MST1 RNAi with in vitro Aurora B phosphorylation and checkpoint rescue (Curr Biol); PHLPP phosphatase and Akt Thr387 kinase assays (Mol Cell); MST1-Sirt1-p53 kinase and acetylation assays (JBC)\",\n      \"pmids\": [\"20080598\", \"20171103\", \"20513427\", \"21212262\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Integration of mitotic versus Hippo roles in vivo not dissected\", \"Sirt1-p53 axis confidence medium and not validated in knockout\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined tyrosine-kinase inputs and ubiquitin-dependent stability control, showing c-Abl phosphorylation at Tyr433 stabilizes and activates MST1 to drive FOXO3-dependent neuronal death under oxidative stress.\",\n      \"evidence\": \"In vitro c-Abl kinase assay, CHIP ubiquitination assay, and MST1-FOXO3 Co-IP in primary neurons\",\n      \"pmids\": [\"21715626\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay between Tyr433 and the later-defined FGFR4 phosphorylation at the same residue unaddressed\", \"CHIP versus other E3 ligase contributions not delineated\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Mechanistically linked MST1 to immune-cell motility by showing phospho-MOB1 recruits the Rac GEF DOCK8, activating Rac1/RhoA to drive thymic egress and migration.\",\n      \"evidence\": \"Mst1/2 double-KO thymocytes with GTP-charging assays and phospho-Mob1/DOCK8 Co-IP\",\n      \"pmids\": [\"22412158\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How a Hippo-core substrate (MOB1) is rewired to cytoskeletal output is not structurally explained\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Extended direct substrate phosphorylation to metabolic and cardiac contexts — PDX1 degradation in beta cells, Bcl-xL Ser14 at mitochondria — and identified the basal-body/AURKA ciliogenesis function.\",\n      \"evidence\": \"In vitro kinase assays with site mapping plus KO/transgenic mice (Nat Med, PDX1); mitochondrial K-Ras/RASSF1A/Mst1 complex and Bcl-xL assays (Mol Cell); AURKA phosphorylation and ciliogenesis in cells/zebrafish (Nat Commun)\",\n      \"pmids\": [\"24633305\", \"24813943\", \"25367221\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants of substrate choice across these contexts not defined\", \"Relationship of ciliary AURKA role to mitotic AURKA role unaddressed\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined mTORC2 as a direct negative regulator phosphorylating Ser438 to block dimerization, and assigned MST1/2 a role in innate immunity by directing mitochondrial recruitment to phagosomes.\",\n      \"evidence\": \"In vitro mTORC2 kinase assay with S438 mutagenesis and cardiac Rictor KO (Cell Rep); Mst1/2-KO macrophages with Rac activation, TRAF6-ECSIT Co-IP, and ROS/bactericidal assays (Nat Immunol)\",\n      \"pmids\": [\"25843706\", \"26414765\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How a SARAH-domain phosphorylation mechanistically disrupts dimer interface not structurally resolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Established MST1 as a brake on innate antiviral signaling (IRF3) and on NF-κB-promoting Th17 responses, and revealed scaffold (DLG5)- and heterodimerization-based mechanisms that suppress MST1 kinase output; also delivered a structurally validated chemical probe (XMU-MP-1) and additional substrates (L-plastin).\",\n      \"evidence\": \"MST1-IRF3 kinase/dimerization assays and KO viral challenge (Genes Dev); DLG5 AP-MS with genetic rescue (Genes Dev); Mst1/Mst2 heterodimer Co-IP and kinase comparison (Curr Biol); XMU-MP-1 co-crystal and regeneration models (Sci Transl Med); L-plastin Thr89 kinase assay (J Immunol); DC-specific MST1 KO p38-IL6-STAT3 axis (Nat Commun); hepatic Sirt1 stabilization in KO mice (BBRC)\",\n      \"pmids\": [\"27125670\", \"28087714\", \"27238285\", \"27535619\", \"27465533\", \"28145433\", \"26903296\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"MST2-specific divergence from MST1 (e.g., IRF3) mechanistically unexplained\", \"Whether scaffold-based inhibition operates in all tissues unresolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed RASSF SARAH heterodimerization biases MST1 substrate selectivity — promoting H2B but suppressing FoxO phosphorylation — providing a mechanism for context-specific output, and added the angiogenic ROS-MST1-FOXO1 endothelial cascade.\",\n      \"evidence\": \"SPR domain mapping with in vitro multi-substrate kinase assays (Sci Rep); endothelial-specific MST1/FOXO1 KO with sprouting angiogenesis models (Nat Commun)\",\n      \"pmids\": [\"28327630\", \"30783090\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis for scaffold-directed substrate switching not determined\", \"RASSF effects assayed only in vitro for substrate selectivity\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Placed MST1 inside the TNF receptor signaling complex as a HOIP/LUBAC-phosphorylating brake on NF-κB, defining a direct non-Hippo immune-regulatory mechanism.\",\n      \"evidence\": \"MST1-TNF-RSC Co-IP, in vitro HOIP kinase assay, LUBAC ubiquitination assay, and MST1-KO NF-κB readouts; Treg DOCK8-LRCHs proteomics and Rac/STAT5 assays (Immunity)\",\n      \"pmids\": [\"30901564\", \"30413360\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How catalytic activity is engaged within the TNF-RSC not detailed\", \"Coordination of MST1 immune-regulatory roles with its Hippo role unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Expanded the direct-substrate map into neuronal (UNC5B, p53), reproductive (Nur77), and identified additional negative regulation by FGFR4 at Tyr433, plus Hippo-independent ROS-pyroptosis tumor suppression.\",\n      \"evidence\": \"In vitro kinase assays with site mapping and KO/rescue for UNC5B Thr428 (PNAS) and Nur77 Thr366 (EBioMedicine); FGFR4 MS-confirmed Tyr433 phosphorylation and mutagenesis (Cell Death Differ); MST1 overexpression caspase-1 pyroptosis with NAC rescue (Mol Cancer Res)\",\n      \"pmids\": [\"32929029\", \"36623453\", \"30903103\", \"30796177\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"FGFR4 and c-Abl both target Tyr433 with opposite outcomes — reconciliation unresolved\", \"Pyroptosis mechanism medium-confidence, not reconstituted in vitro\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Resolved opposing ubiquitin-dependent control of MST1 abundance, with USP46 stabilizing MST1 to enforce YAP suppression and TRAF6 mediating LPS-induced MST1 ubiquitination in a reciprocal NF-κB feedback loop.\",\n      \"evidence\": \"USP46-MST1 Co-IP and ubiquitination/stability assays with HCC models (Exp Cell Res); myeloid-specific MST1 KO with TRAF6 autoubiquitination assays and septic-shock model (CMLS)\",\n      \"pmids\": [\"34029571\", \"32975614\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase(s) opposed by USP46 not identified\", \"Whether USP46 and TRAF6 act on the same MST1 pool unaddressed\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Added cardiovascular (Cx43 Ser255 hemichannel closure) and neurodegenerative (p53-dependent AD-like deficits) functions, broadening MST1's role in endothelial activation and cognition.\",\n      \"evidence\": \"MS substrate identification with hemichannel dye-uptake assay and EC-specific Mst1-KO atherosclerosis model (Circ Res); MST1-p53 Co-IP and p53-KO rescue in 5xFAD mice (Prog Neurobiol)\",\n      \"pmids\": [\"36164986\", \"35525373\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"p53 phosphorylation site not formally mapped\", \"Mechanistic overlap with earlier MST1-Sirt1-p53 axis not integrated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined transcriptional plus post-translational suppression of MST1 by SIRT7, linking deacetylase activity to MST1 promoter repression and acetylation-primed degradation that releases YAP in liver cancer.\",\n      \"evidence\": \"ChIP for SIRT7/H3K18ac on the MST1 promoter, SIRT7-MST1 Co-IP, MS deacetylation site mapping, ubiquitination assay, and xenograft model\",\n      \"pmids\": [\"38288904\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The acetylation-dependent E3 ligase not identified\", \"Relationship between SIRT7 and USP46/TRAF6 control of MST1 unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how MST1 selects among its many divergent substrates and reconciles opposing inputs converging on shared residues (e.g., c-Abl versus FGFR4 at Tyr433), and how scaffold context dictates whether MST1 drives Hippo, apoptotic, or immune-regulatory outputs.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of substrate-selecting MST1 complexes\", \"No unified framework integrating tissue-specific scaffolds with substrate choice\", \"Convergence of opposing tyrosine-kinase inputs at Tyr433 mechanistically unexplained\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [4, 8, 10, 14, 19, 20, 21, 24, 28, 30, 32, 33, 38]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [4, 8, 24, 30]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [33]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2, 7]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 10, 24]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [20, 22, 34]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [21]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [8, 11, 13, 14]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [1, 3, 19, 20, 32]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [9, 24, 30, 31, 36, 40]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [11, 15, 23, 35]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [21, 45]}\n    ],\n    \"complexes\": [\"TNF receptor signaling complex (TNF-RSC)\", \"MST1/2-SAV1 complex\", \"K-Ras/RASSF1A/MST1 mitochondrial complex\"],\n    \"partners\": [\"MOB1\", \"RASSF1\", \"SAV1\", \"DOCK8\", \"AKT1\", \"HOIP\", \"AURKB\", \"USP46\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":{"gene":"MST1","tier":"IDENTITY","verdict":"Identity concern","subtype":"paralog","uniprot_band":"empty","rules_fired":"R3","issue":"R3: opener equates MST1 to different HGNC gene STK4"},"evaluation":{"faith_supported":8,"faith_total":8,"faith_pct":100.0}}